<?xml version="1.0" encoding="UTF-8"?>
<svg height="741.339" width="548.973" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="95.358" x="56.523,58.771,62.515,66.427,68.667,73.077,78.909,80.741,83.317,87.717,92.126,96.125,99.957,102.533,104.365,108.125,112.535,116.863,120.527,124.271,128.687,132.687,137.103,140.935,143.511,145.246,149.574,153.99,155.59,159.986,163.146,167.146,170.978,174.978,177.554,179.386,181.962,185.72199999999998,190.09,194.418,196.738,201.202,205.698,208.274,210.106,216.77,220.602,223.178,226.938,231.305,235.721,238.297,242.129,244.457,247.017,251.488,255.984,259.728,262.888,265.216,269.544,273.96,277.454,280.03,281.862,286.19" svgx:width="0.28,0.47,0.49,0.28,0.55,0.73,0.23,0.32,0.55,0.55,0.5,0.48,0.32,0.23,0.47,0.55,0.54,0.46,0.47,0.55,0.5,0.55,0.48,0.32,0.23,0.54,0.55,0.2,0.55,0.4,0.5,0.48,0.5,0.32,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.56,0.32,0.23,0.83,0.48,0.32,0.47,0.55,0.55,0.32,0.48,0.29,0.32,0.55,0.56,0.47,0.4,0.29,0.54,0.55,0.45,0.32,0.23,0.54,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(LT) with early oxygenation, severity of primary graft dysfunction</text>
   <text y="104.315" x="56.523,58.771,63.019,68.179,73.427,75.675,77.27499999999999,79.597,81.429,86.005,91.125,93.543,100.207,104.535,107.111,109.687,113.519,115.351,117.183,119.679,123.43900000000001,125.858,129.69,134.106,138.58599999999998,140.939,145.354,147.93,151.762,154.09,156.65,159.024,161.352,165.68,170.096,173.672,176.248,178.08,182.408,186.808,189.184,193.512,197.928,201.928,204.321,208.065,212.065,215.897,218.457,220.818,224.65,226.978,229.554,233.554,236.114,238.507,242.251" svgx:width="0.28,0.53,0.64,0.66,0.28,0.2,0.55,0.23,0.57,0.64,0.55,0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.55,0.48,0.55,0.56,0.55,0.55,0.32,0.48,0.29,0.32,0.55,0.29,0.54,0.55,0.45,0.32,0.23,0.54,0.55,0.55,0.54,0.55,0.5,0.55,0.47,0.5,0.48,0.32,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(PGD), ICU mortality and graft function one year after LT</text>
   <text y="113.329" x="56.523,63.099,67.179,69.923,74.419,78.915,83.395,86.723" svgx:width="0.82,0.51,0.34,0.56,0.56,0.57,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Methods:</text>
   <text y="113.329" x="92.693,96.941,99.517,103.845,107.005,111.501,115.5,119.076,121.652,123.484,127.219,131.219,135.326,139.654,144.15,147.31,151.31,153.886,157.718,161.549,164.125,165.957,170.285,174.701,178.533,180.373,184.422,187.582,190.158,194.486,198.982,202.742,206.815,208.647,213.047,217.19,221.03,225.127,229.207,233.287,235.703,240.199,244.199,248.679,252.736,259.4,261.232,264.896,268.896,273.37600000000003,277.454,279.286,283.862,289.022" svgx:width="0.53,0.32,0.54,0.4,0.56,0.5,0.45,0.32,0.23,0.48,0.5,0.55,0.54,0.56,0.4,0.5,0.32,0.48,0.48,0.32,0.23,0.54,0.55,0.48,0.23,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.23,0.55,0.55,0.48,0.55,0.51,0.51,0.3,0.56,0.5,0.56,0.55,0.83,0.23,0.46,0.5,0.56,0.55,0.23,0.57,0.64,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Prospective observational study in a 32-bed mixed ICU.</text>
   <text y="122.344" x="56.523,60.771,63.347,67.675,71.251,75.083,76.915,80.491,82.322,84.813,89.141,93.557,95.389,99.805,101.405,105.562,107.394,111.81,114.386,118.386,120.962,122.794,126.794,131.122,134.866,136.698,141.114,143.433,147.513,149.113,153.354,157.434,159.034,163.219,167.299,171.37900000000002,175.578,180.074,181.906,185.738,188.898,195.562,199.40200000000002,203.584,205.416,209.416,213.248,217.248,219.08,222.28,226.375,232.207,236.207,238.783,242.783,247.012,253.676,257.675,261.507,264.667,268.895,271.471,275.471,279.951,284.202,288.034" svgx:width="0.53,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55,0.2,0.55,0.23,0.55,0.32,0.5,0.32,0.23,0.5,0.54,0.47,0.23,0.55,0.3,0.51,0.2,0.55,0.51,0.2,0.55,0.51,0.51,0.55,0.56,0.23,0.48,0.4,0.83,0.48,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.83,0.5,0.48,0.4,0.54,0.32,0.5,0.56,0.55,0.48,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Procalcitonin, Interleukin-6, 8, 10 plasma levels were measured at</text>
   <text y="131.358" x="56.523,60.603,64.683,67.918,72.334,73.934,77.159,81.238,85.318,88.61,93.026,94.62599999999999,97.851,101.931,106.011,109.303,113.703,116.956,120.788,123.116,125.692,129.692,132.252,135.551,139.295,143.21499999999997,146.436,148.764,151.34,155.668,162.308,165.598,169.678,173.758,177.83800000000002,181.076,184.82,188.732,191.148,193.724,197.723,201.299,203.131,207.627,209.459,213.459,217.875,220.364,223.564,226.827,228.659,233.075,236.651,238.483,242.811,247.307,251.307,255.78699999999998,259.028,263.524,266.1,270.428,273.588,278.084,282.084,285.66,288.236" svgx:width="0.51,0.51,0.55,0.55,0.2,0.55,0.51,0.51,0.55,0.55,0.2,0.55,0.51,0.51,0.55,0.55,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49,0.55,0.29,0.32,0.54,0.83,0.55,0.51,0.51,0.51,0.55,0.47,0.49,0.3,0.32,0.5,0.45,0.23,0.56,0.23,0.5,0.55,0.32,0.4,0.55,0.23,0.55,0.45,0.23,0.54,0.56,0.5,0.56,0.55,0.56,0.32,0.54,0.4,0.56,0.5,0.45,0.32,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">24 h, 48 h, 72 h after LT from 100 LT-recipients included prospect-</text>
   <text y="140.315" x="56.523,58.355,62.187,66.187,68.019,71.763,73.363,76.139,80.387,84.218,86.794,88.626,92.626,97.042,99.618,102.818,105.562,111.394,115.394,117.97,121.97,124.724,127.052,131.38,133.212,135.044,139.372,145.204,149.204,153.684,156.473,160.801,165.217,167.793,169.625,171.465,174.274,178.602,183.018,187.018,189.808,193.552,197.552,201.384,203.944,206.816,210.648,212.976,215.552,219.552,222.112,224.901,228.645,232.557,234.15699999999998,236.977,240.889,242.721,249.385,253.385,256.196,260.028,264.444,268.92400000000004,271.73,275.306,279.138,283.466,286.626" svgx:width="0.23,0.48,0.5,0.23,0.47,0.2,0.55,0.53,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.29,0.54,0.23,0.23,0.54,0.73,0.5,0.56,0.55,0.54,0.55,0.32,0.23,0.23,0.55,0.54,0.55,0.5,0.55,0.47,0.5,0.48,0.32,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49,0.2,0.55,0.49,0.23,0.83,0.5,0.55,0.48,0.55,0.56,0.55,0.45,0.48,0.54,0.4,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ively. Patients were followed until one year after LT. Time and cause</text>
   <text y="149.33" x="56.523,60.851,63.171,65.537,70.033,74.033,77.865,80.441,84.84100000000001,87.194,93.026,97.025,99.601,103.601,105.959,108.535,112.535,116.111,120.439,123.015,127.511,131.511,136.007" svgx:width="0.54,0.29,0.55,0.56,0.5,0.48,0.32,0.55,0.55,0.73,0.5,0.32,0.5,0.55,0.32,0.5,0.45,0.54,0.32,0.56,0.5,0.56,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">of death were recorded.</text>
   <text y="158.344" x="56.523,61.019,65.099,68.427,72.923,74.923,77.667,80.901" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="158.344" x="86.06,90.308,92.884,97.212,100.788,104.62,106.452,110.028,111.86,114.436,118.764,123.08,124.912,129.312,132.661,136.493,139.053,142.355,146.435,150.51500000000001,153.807,158.207,161.461,167.293,171.293,173.869,177.869,181.133,184.965,188.125,191.285,195.613,199.189,201.021,204.853,207.429,211.429,215.909,219.174,225.006,226.838,229.414,233.814,237.089,241.337,245.169,250.665,254.745,257.409,261.241,263.073,268.569,272.649,275.867,280.195,284.027,288.027" svgx:width="0.53,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.73,0.5,0.32,0.5,0.55,0.48,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.53,0.48,0.69,0.51,0.33,0.48,0.23,0.69,0.51,0.55,0.54,0.48,0.5,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Procalcitonin at 24 h were associated with PaO2/FIO2 over</text>
   <text y="167.358" x="56.523,59.099,63.515,67.515,70.299,72.627,74.459,77.035,80.195,82.755,85.606,89.686,93.766,96.605,101.00500000000001,103.861,107.693,112.109,116.589,119.396,121.972,126.388,130.388,133.229,136.389,140.389,144.221,148.221,150.797,152.629,155.205,158.965,161.746,166.073,168.393,171.27,175.518,180.678,185.958,188.732,192.564,195.124,197.972,202.052,206.132,208.971,213.371,216.17,220.002,222.33,224.906,228.906,231.466,234.312,238.056,241.976,244.8,247.048,251.544,254.12,258.448,262.024,265.855,267.687,271.263,273.095,275.671,279.999,284.415,286.186" svgx:width="0.32,0.55,0.5,0.55,0.29,0.23,0.32,0.4,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.48,0.55,0.56,0.55,0.32,0.55,0.5,0.55,0.4,0.5,0.48,0.5,0.32,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.53,0.64,0.66,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49,0.55,0.28,0.56,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">the first 72 h and the severity of PGD at 72 h after LT (procalcitonin</text>
   <text y="176.316" x="56.523,60.355,62.915,65.423,69.503,73.583,76.082,80.482,82.998,87.326,89.64599999999999,92.126,96.622,100.454,103.03,104.862,108.862,113.278,115.854,119.054,121.493,127.325,129.157,131.733,136.133,138.615,143.031,145.606,149.438,153.934,157.934,160.442,164.521,166.937,171.01700000000002,173.481,177.729,182.888,188.168,190.602,196.434,200.434,203.01,207.01,209.538,214.034,215.866,218.194,220.522,224.522,227.098,231.097,235.513,238.073,240.492,242.82,245.396,249.724,256.364,258.917,261.493,265.909,270.237,273.397,277.397,279.837,284.333,288.165" svgx:width="0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.54,0.29,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.55,0.32,0.48,0.56,0.5,0.55,0.51,0.3,0.51,0.55,0.53,0.64,0.66,0.55,0.73,0.5,0.32,0.5,0.55,0.56,0.23,0.29,0.29,0.5,0.32,0.5,0.55,0.32,0.55,0.29,0.32,0.54,0.83,0.55,0.32,0.55,0.54,0.4,0.5,0.55,0.56,0.48,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">at 24 h of patients with grade 0-2 PGD were different from those pa-</text>
   <text y="185.33" x="56.523,59.099,60.931,64.931,69.347,71.923,75.123,78.69,84.522,86.354,88.93,93.33000000000001,96.945,101.361,103.937,107.769,112.264,116.264,119.848,123.928,127.616,131.863,137.023,142.271,144.511,148.138,150.386,154.86599999999999,156.416,161.136,162.765,166.845,168.421,172.501,176.581,178.829,180.429,184.025,188.273,192.849,196.76899999999998,200.353,202.185,206.185,210.017,214.017,215.849,219.04899999999998,222.634,226.465,229.025,232.668,236.748,240.828,244.46,248.86,252.51,258.342,262.174,265.37399999999997,268.951,273.367,275.198,279.614,284.03,288.03" svgx:width="0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.55,0.32,0.48,0.56,0.5,0.55,0.51,0.55,0.53,0.64,0.66,0.28,0.55,0.28,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.28,0.2,0.55,0.53,0.57,0.49,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.73,0.48,0.4,0.55,0.55,0.23,0.55,0.55,0.5,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">tients with grade 3 PGD) (p &lt; 0.01). PCT levels at 24 h was higher</text>
   <text y="194.344" x="56.523,58.851,61.427,65.755,72.395,76.762,79.338,83.754,87.754,92.126,96.206,100.573,105.069,108.901,111.477,113.308,117.308,121.724,124.3,127.5,131.811,137.643,142.059,146.379,150.746,155.242,157.074,161.074,165.57,167.17,171.496,173.744,178.224,179.773,184.493,186.123,190.203,191.779,195.859,199.939,202.187,203.787,208.119,212.951,218.111,222.671,224.22,228.94,230.569,234.649,236.225,240.305,244.38500000000002,248.711,253.207,255.783,259.783,264.279,266.111,269.687,272.247,276.66,278.492,283.068,288.228" svgx:width="0.29,0.32,0.54,0.83,0.55,0.32,0.55,0.5,0.55,0.51,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.55,0.54,0.55,0.56,0.23,0.5,0.56,0.2,0.55,0.28,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.28,0.2,0.55,0.6,0.64,0.57,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.55,0.56,0.32,0.5,0.56,0.23,0.45,0.32,0.55,0.23,0.57,0.64,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">from the 9 patients who died, (p = 0.02), AUC = 0.74 predict ICU-</text>
   <text y="203.358" x="56.523,63.187,67.515,70.091,72.667,76.499,78.236,80.068,82.644,86.388,87.988,91.332,95.58,98.156,102.484,106.06,109.892,111.724,115.3,117.132,119.708,124.036,128.452,130.283,134.683,137.991,141.823,146.238,150.718,154.091,155.923,160.339,162.915,166.915,169.491,171.323,175.323,179.651,183.288,185.12,189.536,191.952,196.032,200.11200000000002,203.471,207.303,209.863,213.222,217.302,221.382,224.731,229.147,230.74699999999999,234.085,238.165,242.245,245.594,250.01,251.60999999999999,254.948,259.028,263.108,266.457,270.85699999999997,274.224,280.056,284.056,286.632" svgx:width="0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.2,0.55,0.53,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55,0.55,0.48,0.55,0.56,0.55,0.23,0.55,0.32,0.5,0.32,0.23,0.5,0.54,0.47,0.23,0.55,0.3,0.51,0.51,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.2,0.55,0.51,0.51,0.55,0.55,0.2,0.55,0.51,0.51,0.55,0.55,0.55,0.73,0.5,0.32,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">mortality. Procalcitonin and interleukin-10 at 24 h, 48 h, 72 h were</text>
   <text y="212.316" x="56.523,60.099,64.427,67.003,69.579,73.579,75.411,79.243,81.818,85.72,90.2,93.941,99.773,101.605,104.181,108.581,112.252,114.828,119.244,123.244,126.88,130.711,134.623,139.039,143.119,146.778,151.106,155.522,159.522,163.219,166.963,170.963,174.795,177.355,181.02,184.852,187.18,189.756,193.756,196.316,200.012,203.756,207.668,209.268,212.938,214.77,219.186,221.762,225.762,228.338,230.17,234.17,238.498,242.242,244.074,248.49,250.809,254.889,258.969,262.658,266.49,269.05,272.749,276.829,280.909,284.598,289.013" svgx:width="0.45,0.54,0.32,0.32,0.5,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.48,0.49,0.55,0.51,0.55,0.54,0.55,0.5,0.55,0.47,0.5,0.48,0.32,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49,0.2,0.55,0.23,0.55,0.32,0.5,0.32,0.23,0.5,0.54,0.47,0.23,0.55,0.3,0.51,0.51,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">correlated with the FEV1 one year after LT. Interleukin-10 at 48 h,</text>
   <text y="221.33" x="56.523,60.355,62.187,65.347,69.667,72.0,77.832,81.832,84.408,88.408,90.766,94.342,98.669,101.245,103.821,107.821,109.653,113.485,116.061,120.061,124.54100000000001,126.936,132.767,134.599,137.175,141.57500000000002,143.943,146.519,150.935,154.935,157.323,161.155,165.571,170.131,172.517,176.844,181.26,185.26,187.597,191.341,195.341,199.173,201.733,204.095,207.926,210.254,212.83,216.83,219.39000000000001,221.783,225.527" svgx:width="0.48,0.23,0.4,0.54,0.55,0.73,0.5,0.32,0.5,0.55,0.45,0.54,0.32,0.32,0.5,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.32,0.55,0.5,0.55,0.48,0.55,0.57,0.55,0.54,0.55,0.5,0.55,0.47,0.5,0.48,0.32,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.49" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">also were correlated with the FVC one year after LT</text>
   <text y="230.344" x="56.523,61.187,65.683,70.179,73.755,75.755,80.251,83.578,85.578,89.972,94.468,97.796" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="230.344" x="102.784,107.944,109.776,114.192,118.608,122.608,125.168,128.296,130.127,134.127,137.959,141.959,143.791,146.99099999999999,150.122,154.45,156.76999999999998,159.93,164.426,167.002,171.33,174.906,178.738,180.57,184.146,185.978,188.554,192.812,197.228,199.06,203.46,206.646,210.478,213.038,216.227,220.307,224.387,227.509,231.909,235.105,237.433,241.761,243.593,245.425,249.753,255.585,257.417,261.833,266.233,269.348,273.092,277.012,280.177,284.009,286.585" svgx:width="0.64,0.23,0.55,0.55,0.5,0.32,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.54,0.29,0.55,0.56,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.29,0.54,0.23,0.23,0.54,0.73,0.23,0.55,0.55,0.55,0.47,0.49,0.55,0.48,0.32,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Higher levels of procalcitonin at 24 h following LT are</text>
   <text y="239.359" x="56.523,60.355,63.515,66.675,71.003,74.579,76.411,80.243,82.818,86.74,91.22,94.337,100.169,102.001,104.577,108.977,112.081,116.497,119.073,122.905,127.401,131.401,134.419,138.49900000000002,141.619,145.866,151.026,156.306,159.363,163.195,165.755,168.888,172.968,177.048,180.113,184.513,187.653,191.485,195.901,200.381,203.471,205.303,209.879,214.999,218.098,224.762,229.089,231.665,234.241,238.073,239.905,241.737,244.313,248.057,249.65699999999998,252.68,254.512,258.928,261.504,265.504,268.08,269.912,273.912,278.24,281.984,283.816,288.232" svgx:width="0.48,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.55,0.32,0.48,0.56,0.5,0.55,0.51,0.55,0.53,0.64,0.66,0.55,0.48,0.32,0.55,0.51,0.51,0.55,0.55,0.55,0.48,0.55,0.56,0.55,0.23,0.57,0.64,0.55,0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.2,0.55,0.23,0.55,0.32,0.5,0.32,0.23,0.5,0.54,0.47,0.23,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">associated with grade 3 PGD at 72 h and ICU mortality. Interleukin-</text>
   <text y="248.316" x="56.523,60.603,64.683,67.521,71.353,75.769,80.24900000000001,83.111,87.359,89.935,94.263,97.839,101.671,103.503,107.079,108.911,111.487,115.815,120.132,121.964,126.364,129.26,131.091,135.091,138.923,142.923,144.755,147.95499999999998,150.746,155.242,159.57,162.146,163.978,168.394,172.794,175.635,179.715,183.79500000000002,186.633,191.03300000000002,193.947,198.443,202.771,205.931,208.507,211.082,213.658,217.49,221.906,225.066,229.493,231.325,235.157,239.573,242.149,245.981,248.557,250.389,254.717,259.117,261.922,267.754,271.754,274.33,278.33,281.198,285.03,288.189" svgx:width="0.51,0.51,0.55,0.48,0.55,0.56,0.55,0.53,0.32,0.54,0.45,0.48,0.23,0.45,0.23,0.32,0.54,0.55,0.23,0.55,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.56,0.54,0.32,0.23,0.55,0.55,0.55,0.51,0.51,0.55,0.55,0.55,0.56,0.54,0.4,0.32,0.32,0.32,0.48,0.55,0.4,0.56,0.23,0.48,0.55,0.32,0.48,0.32,0.23,0.54,0.55,0.55,0.73,0.5,0.32,0.5,0.55,0.48,0.4,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">10 and Procalcitonin levels during 72 h posttransplantation were as-</text>
   <text y="257.331" x="56.523,59.683,64.011,67.587,69.419,73.251,75.742,79.742,84.22200000000001,86.626,92.458,94.29,96.866,101.266,103.634,108.13,111.962,114.538,116.37,120.37,124.786,127.362,130.56199999999998,132.887,138.719,140.551,143.127,147.52700000000002,149.895,155.727,160.055,162.631,165.791,169.791,172.176,176.592,179.168,183.0,185.328,187.888,190.261,192.589,196.917,201.333,204.909,207.485,209.317,213.645,218.04500000000002,220.422,224.253,226.581,229.157,233.157,235.717,238.11,242.438,246.854,250.854,253.191,256.935,260.935,264.767,267.343" svgx:width="0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.73,0.54,0.32,0.4,0.5,0.55,0.55,0.32,0.48,0.29,0.32,0.55,0.29,0.54,0.55,0.45,0.32,0.23,0.54,0.55,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.54,0.55,0.5,0.55,0.47,0.5,0.48,0.32,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">sociated with patients with worse graft function after one year.</text>
   <text y="478.602" x="56.523,61.099,65.515,69.931" svgx:width="0.57,0.55,0.55,0.55" style="fill:rgb(235,103,59);font-family:AdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;">P267</text>
   <text y="487.56" x="56.523,61.851,65.931,71.851,74.155,80.899,85.394,87.394,91.474,95.05,99.546,101.546,105.546,108.346,110.721,115.385,117.385,121.881,128.625,132.625,135.457,139.457,143.433,146.265,149.625,151.994,156.49,158.97,161.405,165.405,168.981,173.477,176.221,180.30100000000002,182.608,185.44,189.52,192.848,197.512,199.511,202.343,206.343,209.087,213.583,216.415,220.415,222.746,227.322,229.322,232.65,235.394,238.226,242.306,245.634,248.994,251.32,254.648,258.648,263.144,267.719,270.551,275.047,281.791" svgx:width="0.67,0.51,0.74,0.55,0.84,0.56,0.25,0.51,0.45,0.56,0.25,0.5,0.35,0.55,0.58,0.25,0.56,0.84,0.5,0.35,0.5,0.51,0.35,0.42,0.55,0.56,0.31,0.55,0.5,0.45,0.56,0.34,0.51,0.55,0.35,0.51,0.42,0.58,0.25,0.35,0.5,0.34,0.56,0.35,0.5,0.55,0.57,0.25,0.42,0.34,0.35,0.51,0.42,0.42,0.55,0.42,0.5,0.56,0.57,0.35,0.56,0.84,0.51" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">New molecular biomarkers of acute respiratory distress syndrome</text>
   <text y="496.574" x="56.523,58.523,63.003,65.367,69.367,74.031,78.607,83.102,89.846,91.846,96.342,100.342,102.342,104.655,107.983,112.063,116.727,120.055,122.055" svgx:width="0.25,0.56,0.55,0.5,0.58,0.57,0.56,0.84,0.25,0.56,0.5,0.25,0.55,0.42,0.51,0.58,0.42,0.25,0.42" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">in abdominal sepsis</text>
   <text y="505.588" x="56.523,61.187,62.547,64.856,68.768,70.128,72.51,76.422,80.582,83.742,87.99,91.566,93.23,97.061" svgx:width="0.58,0.17,0.55,0.49,0.17,0.55,0.49,0.52,0.4,0.53,0.45,0.21,0.48,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">A. K. Kuzovlev</text>
   <text y="502.016" x="100.573" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="505.587" x="103.465,104.825,107.206,111.206,112.566,114.916,121.076,125.324,127.652,131.9" svgx:width="0.17,0.55,0.5,0.17,0.55,0.77,0.53,0.29,0.53,0.4" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, V. Moroz</text>
   <text y="502.016" x="134.986" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="505.587" x="137.877,139.23700000000002,141.619,146.283,147.643,150.009,154.921,159.169,160.833,165.081,169.241,173.569,177.401" svgx:width="0.17,0.55,0.58,0.17,0.55,0.61,0.53,0.21,0.53,0.52,0.54,0.48,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, A. Goloubev</text>
   <text y="502.016" x="180.907" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="505.587" x="183.742,185.102,187.483,191.147,192.507,194.854,198.854,203.101,204.765,209.013,212.589,216.837,218.501,221.829,226.077" svgx:width="0.17,0.55,0.46,0.17,0.55,0.5,0.53,0.21,0.53,0.45,0.53,0.21,0.42,0.53,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, S. Polovnikov</text>
   <text y="502.016" x="229.606" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="505.587" x="232.498,233.858,236.182,239.846,241.20600000000002,243.609,248.689,252.521,256.769,260.265,264.513,268.673" svgx:width="0.17,0.55,0.46,0.17,0.55,0.63,0.48,0.53,0.44,0.53,0.52,0.42" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, S. Nenchuk</text>
   <text y="502.016" x="271.899" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="511.03" x="56.523" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="514.602" x="59.357,63.357,64.685,69.349,70.709,73.077,78.157,81.989,86.317,90.565,94.141,97.053,100.29,103.81,106.186,110.186,114.018,116.93,120.762,124.337,126.665,130.161,134.401,136.743,138.407,142.655,145.567,147.983,149.647,152.063,156.223,158.639,162.479,164.806,169.054,171.13400000000001,173.537,178.449,182.281,186.529,190.361,192.689,196.265,197.945,200.296,204.296,208.128,211.704,215.952,217.616,224.111,227.687,230.003,234.251,235.915,240.162,244.49,247.986,249.346,251.716,257.876,262.124,265.036,268.532,272.78,278.418" svgx:width="0.5,0.17,0.58,0.17,0.55,0.63,0.48,0.54,0.53,0.45,0.36,0.42,0.44,0.55,0.5,0.48,0.36,0.48,0.45,0.29,0.44,0.53,0.55,0.21,0.53,0.36,0.3,0.21,0.3,0.52,0.3,0.48,0.55,0.53,0.26,0.55,0.61,0.48,0.53,0.48,0.29,0.45,0.21,0.55,0.5,0.48,0.45,0.53,0.21,0.81,0.45,0.3,0.53,0.21,0.53,0.54,0.44,0.17,0.55,0.77,0.53,0.36,0.44,0.53,0.72,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">V.A. Negovsky Research Institute of General Reanimatology, Moscow,</text>
   <text y="523.559" x="56.523,60.523,64.683,67.595,70.507,72.171,75.747" svgx:width="0.5,0.52,0.36,0.36,0.21,0.45,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Russia;</text>
   <text y="520.044" x="79.427" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="523.559" x="82.261,87.341,92.381,94.847,98.847,103.007,105.335,109.663,113.495,117.638,120.966,125.20599999999999,127.616,133.776,137.352,139.016,143.256,145.645,151.805,153.469,155.132,156.796,159.212,162.788,165.116,168.63600000000002,170.987,175.987,180.235,183.147,187.474,189.138,191.554,195.13,196.794,198.15400000000002,200.467,206.627,210.875,213.787,217.283,221.531,227.275,228.63500000000002,230.912,234.912,239.071,241.983,244.895,246.559" svgx:width="0.63,0.63,0.55,0.5,0.52,0.29,0.54,0.48,0.53,0.42,0.53,0.55,0.77,0.45,0.21,0.53,0.55,0.77,0.21,0.21,0.21,0.3,0.45,0.29,0.44,0.55,0.63,0.53,0.36,0.54,0.21,0.3,0.45,0.21,0.17,0.55,0.77,0.53,0.36,0.44,0.53,0.72,0.17,0.55,0.5,0.52,0.36,0.36,0.21,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">NN Burdenko Main Military Hospital, Moscow, Russia</text>
   <text y="532.573" x="56.523,60.558,62.694,64.191,66.402,67.9,70.985,74.785,76.38499999999999,78.519,82.555,86.355,88.554" svgx:width="0.53,0.28,0.2,0.29,0.2,0.41,0.5,0.2,0.55,0.53,0.5,0.28,0.42" style="fill:rgb(19,20,19);font-family:AdvTT1b53b5fb.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="532.573" x="93.997,97.637,101.277,104.918,108.558" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">2016,</text>
   <text y="532.573" x="112.139,116.174,120.21,122.421,126.297,130.568,134.999,139.521,141.521,143.716,147.752,149.963" svgx:width="0.53,0.53,0.29,0.51,0.56,0.58,0.58,0.25,0.55,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">20(Suppl 2):</text>
   <text y="532.573" x="151.711,155.51,159.151,162.791" svgx:width="0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">P267</text>
   <text y="550.602" x="56.523,58.603,63.099,65.843,68.675,73.171,77.747,82.148,85.724,88.468,90.468,94.964,99.46,102.788" svgx:width="0.26,0.56,0.34,0.35,0.56,0.57,0.56,0.45,0.34,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Introductions:</text>
   <text y="550.602" x="107.66,112.492,116.068,120.396,122.972,126.972,129.997,132.573,136.573,139.733,144.229,146.061,148.637,152.469,155.045,159.373,161.858,165.618,168.661,173.157,174.989,178.149,180.725,183.301,187.301,190.461,193.661,196.611,199.771,203.515,207.931,212.426,215.002,219.33,225.994,229.994,233.008,235.256,240.088,244.336,249.584,253.496,255.73600000000002,258.747,260.579,263.779,266.74,270.58,273.657,277.233,281.561,288.225" svgx:width="0.6,0.45,0.54,0.32,0.5,0.55,0.32,0.5,0.4,0.56,0.23,0.32,0.48,0.32,0.54,0.32,0.47,0.55,0.56,0.23,0.4,0.32,0.32,0.5,0.4,0.4,0.55,0.4,0.47,0.55,0.56,0.32,0.54,0.83,0.5,0.55,0.28,0.6,0.53,0.66,0.49,0.28,0.55,0.23,0.4,0.55,0.48,0.55,0.45,0.54,0.83,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Acute respiratory distress syndrome (ARDS) is a com-</text>
   <text y="559.559" x="56.523,63.187,67.515,71.915,75.742,79.318,83.646,90.31,94.806,96.637,98.469,102.045,105.789,108.365,110.197,114.525,118.92500000000001,122.74,127.068,129.388,133.285,137.701,142.029,145.189,149.517,153.093,157.421,164.085,165.827,169.659,171.499,175.352,179.848,184.264,188.264,192.591,199.255,203.471,207.887,209.719,213.559,217.418,219.665,224.913,229.161,231.401,235.219,237.051,241.451,245.31,249.806,253.638,256.214,258.046,262.046,266.462,269.038,272.238,275.981,281.813,283.645,286.221" svgx:width="0.83,0.54,0.55,0.55,0.45,0.54,0.83,0.56,0.23,0.23,0.45,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.55,0.54,0.4,0.54,0.45,0.54,0.83,0.23,0.48,0.23,0.55,0.56,0.55,0.5,0.54,0.83,0.54,0.55,0.23,0.48,0.55,0.28,0.66,0.53,0.28,0.55,0.23,0.55,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">mon complication of nosocomial pneumonia (NP) in patients with</text>
   <text y="568.573" x="56.523,60.355,64.851,69.347,73.675,80.338,82.17,86.457,90.289,92.129,95.074,98.234,102.234,106.73,109.89,111.722,114.882,116.482,119.339,123.251,127.667,131.667,134.589,138.421,140.253,146.89299999999997,149.782,154.11,156.43,159.364,161.94,166.356,168.188,171.38799999999998,174.274,177.434,180.01,184.338,188.834,192.594,195.477,201.309,205.141,208.34099999999998,211.181,213.757,218.077,220.989,222.821,227.237,231.069,235.069,238.228,240.804,242.636,247.052,250.884,253.46,257.46000000000004,260.334,262.166,266.582,269.158,273.478,276.378,280.794,284.793" svgx:width="0.48,0.56,0.56,0.54,0.83,0.23,0.55,0.48,0.23,0.55,0.4,0.5,0.56,0.4,0.23,0.4,0.2,0.55,0.49,0.55,0.5,0.55,0.48,0.23,0.83,0.55,0.54,0.29,0.55,0.32,0.55,0.23,0.4,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.73,0.48,0.4,0.55,0.32,0.54,0.55,0.23,0.55,0.48,0.5,0.4,0.32,0.23,0.55,0.48,0.32,0.5,0.55,0.23,0.55,0.32,0.54,0.55,0.55,0.5,0.73" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">abdominal sepsis. The aim of this study was to investigate into new</text>
   <text y="577.588" x="56.523,63.187,67.515,69.347,73.347,76.923,81.25,83.082,86.797,89.357,91.786,96.282,98.113,102.441,109.105,112.937,115.513,119.257,123.257,125.744,128.944,131.3,135.628,137.94799999999998,140.371,145.203,149.451,154.699,158.619,160.951,162.783,167.183,169.569,173.401,177.896,182.392,186.72,193.384,195.216,199.632,203.464,205.304,207.61,210.77,214.77,219.266,222.425,224.257,227.417" svgx:width="0.83,0.54,0.23,0.5,0.45,0.54,0.23,0.48,0.32,0.55,0.56,0.23,0.54,0.83,0.48,0.32,0.47,0.5,0.32,0.4,0.55,0.54,0.29,0.55,0.6,0.53,0.66,0.49,0.55,0.23,0.55,0.55,0.48,0.56,0.56,0.54,0.83,0.23,0.55,0.48,0.23,0.55,0.4,0.5,0.56,0.4,0.23,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">molecular biomarkers of ARDS in abdominal sepsis.</text>
   <text y="586.602" x="56.523,63.099,67.179,69.923,74.419,78.915,83.395,86.723" svgx:width="0.82,0.51,0.34,0.56,0.56,0.57,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Methods:</text>
   <text y="586.602" x="92.182,96.094,100.51,104.51,108.113,112.441,116.937,120.097,124.097,126.673,130.505,134.249,136.825,138.657,142.985,147.401,151.233,153.073,156.643,159.803,162.379,166.707,171.203,174.963,178.584,180.416,184.816,188.392,190.223,194.799,199.919,203.585,207.417,211.417,215.833,218.409,220.241,222.073,225.905,228.481,232.385,236.86499999999998,240.492,243.652,247.652,252.148,254.724,256.556,260.156,263.737,268.233,272.065,274.641,276.473,280.473,284.889,287.465" svgx:width="0.49,0.55,0.5,0.55,0.54,0.56,0.4,0.5,0.32,0.48,0.48,0.32,0.23,0.54,0.55,0.48,0.23,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.23,0.55,0.55,0.23,0.57,0.64,0.55,0.48,0.5,0.55,0.32,0.23,0.23,0.48,0.32,0.5,0.56,0.55,0.4,0.5,0.56,0.32,0.23,0.45,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">The observational study in ICU ventilated septic patients</text>
   <text y="595.559" x="56.523,62.355,64.187,66.763,71.16300000000001,73.814,78.31,82.31,84.886,86.718,89.294,93.622,98.037,99.779,102.355,104.187,107.387,110.041,112.288,116.368,120.448,123.08,129.407,131.64700000000002,134.305,138.137,142.553,147.033,149.726,154.222,158.054,162.469,166.045,168.621,172.621,176.949,181.247,185.247,188.823,191.399,195.727,198.887,200.719,203.91899999999998,206.532,208.78,212.86,216.94000000000003,219.571,225.899,228.139,230.853,236.685,240.517,243.71699999999998,246.274,250.77,254.77,257.346,259.674,264.002,266.578,273.242,277.242,281.72200000000004,284.372,286.204" svgx:width="0.73,0.23,0.32,0.55,0.55,0.56,0.5,0.32,0.23,0.32,0.54,0.55,0.23,0.32,0.23,0.4,0.55,0.28,0.51,0.51,0.55,0.79,0.28,0.55,0.48,0.55,0.56,0.55,0.56,0.48,0.55,0.45,0.32,0.5,0.54,0.55,0.5,0.45,0.32,0.54,0.4,0.23,0.4,0.55,0.28,0.51,0.51,0.55,0.79,0.28,0.55,0.73,0.48,0.4,0.55,0.56,0.5,0.32,0.29,0.54,0.32,0.83,0.5,0.56,0.55,0.23,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">with peritonitis (76 %) and pancreonecrosis (24 %) was performed in</text>
   <text y="604.574" x="56.523,60.603,64.683,68.763,72.843,76.309,80.141,84.557,89.037,92.58,96.66,100.74,104.82,108.9,110.5,113.953,118.785,123.033,128.281,132.201,135.667,141.499,145.33,148.53,151.994,156.49,158.322,162.154,166.57,170.986,175.314,178.474,182.474,186.95399999999998,190.432,194.264,198.68,203.16,206.703,209.863,212.439,216.271,220.687,224.687,229.167,232.669,236.501,240.076,243.652,247.98,250.556,255.052,256.884,261.3,265.7,269.179,271.754,276.074,279.61,282.186,286.602" svgx:width="0.51,0.51,0.51,0.51,0.55,0.48,0.55,0.56,0.55,0.51,0.51,0.51,0.51,0.2,0.55,0.6,0.53,0.66,0.49,0.55,0.73,0.48,0.4,0.55,0.56,0.23,0.48,0.55,0.55,0.54,0.4,0.5,0.56,0.55,0.48,0.55,0.56,0.55,0.4,0.32,0.48,0.55,0.5,0.56,0.55,0.48,0.45,0.45,0.54,0.32,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.32,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">2010 and 2015. ARDS was diagnosed and staged according to the</text>
   <text y="613.588" x="56.523,60.939,62.515,67.347,68.94699999999999,73.02,78.268,82.268,86.684,91.012,94.844,98.004,101.748,105.50800000000001,109.644,113.892,117.892,121.052,125.052,128.883,131.357,134.933,139.333,143.546,145.378,149.794,152.954,155.53,157.361,159.937,164.265,166.841,170.841,174.953,178.529,181.105,182.937,185.513,189.513,192.089,193.921,197.761,201.883,205.715,210.13,214.60999999999999,218.777,221.353,225.769,229.769,233.913,238.241,242.241,244.817,246.649,248.481,252.881,257.044,261.54,265.54,267.868,269.7,274.116,275.948,278.524,280.356,284.597,289.013" svgx:width="0.55,0.2,0.6,0.2,0.55,0.66,0.5,0.55,0.54,0.48,0.4,0.47,0.47,0.55,0.53,0.5,0.4,0.5,0.48,0.32,0.45,0.55,0.55,0.23,0.55,0.4,0.32,0.23,0.32,0.54,0.32,0.5,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.48,0.55,0.48,0.55,0.56,0.55,0.32,0.55,0.5,0.55,0.54,0.5,0.32,0.23,0.23,0.55,0.55,0.56,0.5,0.29,0.23,0.55,0.23,0.32,0.23,0.54,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">V.A. Negovsky Research Institute criteria and the Berlin definition.</text>
   <text y="622.602" x="56.523,60.771,62.603,66.435,69.595,76.259,80.099,82.545,85.705,90.033,92.609,94.937,98.769,102.345,104.921,108.753,113.169,115.729,118.261,122.757,125.333,129.661,132.237,136.237,138.069,142.469,144.963,149.763,152.334,156.166,160.582,165.06199999999998,167.584,172.864,175.351,177.599,181.511,185.759,191.007,192.607,195.08,198.992,203.24,208.072,210.312,212.825,218.657,222.657,225.233,229.233,231.761,238.425,242.424,246.256,249.416,253.744,256.32,260.22,264.70000000000005,267.25,271.578,275.97799999999995,278.532,283.028,286.86" svgx:width="0.53,0.23,0.48,0.4,0.83,0.48,0.55,0.4,0.54,0.32,0.29,0.48,0.45,0.32,0.48,0.55,0.32,0.55,0.56,0.32,0.54,0.32,0.5,0.23,0.55,0.55,0.6,0.55,0.48,0.55,0.56,0.55,0.66,0.55,0.28,0.49,0.53,0.66,0.2,0.55,0.49,0.53,0.6,0.28,0.55,0.73,0.5,0.32,0.5,0.55,0.83,0.5,0.48,0.4,0.54,0.32,0.5,0.56,0.55,0.54,0.55,0.55,0.56,0.48,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Plasma surfactant protein A and D (SPD, SPA) were measured on day</text>
   <text y="631.56" x="56.523,60.603,62.203,66.784,70.864,72.464,77.046,81.126,85.663,90.255,94.015,98.533,101.197,105.676,109.676,114.236,116.164,122.91,129.574,134.022,138.5,142.923,147.004,151.482,154.998,158.853,165.517,169.517,174.103,178.184,181.416,184.647,188.559,192.319,196.892,199.217,203.545,205.51,209.932,214.41,218.492,222.97,227.562,231.985,234.649,236.249,240.772,245.932,250.013,254.845,257.27,258.87,263.393,267.702,271.614,274.278,276.206,280.287,284.766,287.431" svgx:width="0.51,0.2,0.55,0.51,0.2,0.55,0.51,0.55,0.56,0.47,0.55,0.32,0.55,0.5,0.55,0.23,0.83,0.83,0.54,0.55,0.54,0.5,0.55,0.43,0.47,0.83,0.5,0.55,0.5,0.4,0.4,0.48,0.47,0.55,0.28,0.54,0.23,0.54,0.55,0.5,0.55,0.56,0.54,0.32,0.2,0.55,0.64,0.49,0.6,0.28,0.2,0.55,0.53,0.48,0.32,0.23,0.5,0.55,0.32,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">0, 3, 5 by the immunoenzyme essay (BioVendor, USA). Patients</text>
   <text y="640.574" x="56.523,62.438,66.521,69.18,73.18,76.72,79.379,82.038,86.122,90.037,92.696,96.779,101.259,104.829,108.745,112.404,115.98,120.454,123.113,127.692,129.524,134.099,138.499,142.035,144.7,149.01999999999998,152.637,155.302,159.801,163.801,167.341,169.256,173.755,176.414,180.497,183.156,187.656,191.571,194.23,196.145,200.556,205.055,208.97,210.81,214.413,218.891,223.302,225.134,229.765,233.847,235.762,237.677,242.176,246.26,249.503,251.10299999999998,254.662,259.991,263.907,266.566,270.40599999999995,273.936,279.832,283.915,286.574" svgx:width="0.73,0.5,0.32,0.5,0.55,0.32,0.32,0.5,0.48,0.32,0.5,0.56,0.55,0.48,0.45,0.45,0.54,0.32,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.32,0.55,0.5,0.55,0.23,0.55,0.32,0.5,0.32,0.55,0.48,0.32,0.23,0.54,0.55,0.48,0.23,0.55,0.55,0.54,0.23,0.56,0.5,0.23,0.23,0.55,0.5,0.4,0.2,0.55,0.66,0.48,0.32,0.48,0.55,0.73,0.5,0.32,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">were treated according to the international guidelines. Data were</text>
   <text y="649.588" x="56.523,59.754,62.419,66.331,68.995,70.923,74.154,76.819,78.746,82.322,86.286,88.213,90.14,93.9,97.51,101.422,105.901,109.813,111.74,115.595,119.011,123.135,127.61500000000001,131.242,135.834,139.594,143.204,147.23,151.142,156.13,160.042,162.026,165.938,170.02,171.947,176.596,181.39600000000002,185.043,189.123,190.882,194.962,196.56199999999998,200.236,205.168,210.497,215.993,220.531,225.33100000000002,228.978,232.89,237.369,241.849,245.532,250.028,252.732,256.814,260.102,264.102,268.663,271.327,275.409,279.889,283.516,287.428" svgx:width="0.4,0.32,0.48,0.32,0.23,0.4,0.32,0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.48,0.55,0.48,0.23,0.47,0.43,0.5,0.56,0.55,0.56,0.47,0.55,0.49,0.49,0.6,0.49,0.23,0.49,0.49,0.23,0.57,0.6,0.55,0.51,0.2,0.51,0.2,0.55,0.6,0.66,0.69,0.55,0.6,0.55,0.48,0.55,0.56,0.55,0.56,0.32,0.5,0.4,0.5,0.55,0.32,0.5,0.56,0.55,0.48,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">statistically analyzed by STATISTICA 7.0, ANOVA and presented as</text>
   <text y="658.603" x="56.523,63.187,67.295,71.887,73.814,77.726,82.126,86.173,90.085,94.563,99.043,103.067,107.262,111.342,113.895,117.975,122.228,124.893,129.293,133.34,137.836,141.958,144.623,148.307,152.389,156.867,159.532,161.459,163.386,167.468,170.66799999999998,174.668,176.993,181.471,185.949,188.727,195.473,197.305,199.668,201.268,205.338,209.81799999999998,211.461,216.181,217.867,221.947,223.706,227.786,231.866,235.952,241.848,245.76,248.95999999999998,252.96,256.644,261.067,265.546,268.777,270.704,275.296,279.378,282.042,286.124" svgx:width="0.83,0.5,0.56,0.23,0.48,0.55,0.55,0.48,0.55,0.56,0.55,0.51,0.51,0.3,0.51,0.51,0.32,0.55,0.55,0.56,0.5,0.32,0.45,0.5,0.55,0.32,0.23,0.23,0.5,0.4,0.55,0.28,0.55,0.55,0.33,0.83,0.23,0.28,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.55,0.73,0.48,0.4,0.55,0.45,0.54,0.55,0.4,0.23,0.56,0.5,0.32,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">median and 25-75th percentiles (ng/ml); p &lt; 0.05 was considered</text>
   <text y="667.56" x="56.523,59.768,62.43,66.347,69.009,70.927,74.172,76.834,78.751,82.327,86.291,88.209,90.126,93.88600000000001,97.894,101.139,103.057,107.558,112.06,113.977,116.391,118.223,121.947,125.859,130.36,133.022,134.62199999999999,138.635,143.467,146.128,150.214,154.131,157.331,161.331,165.659,170.232,174.728,178.849,181.409,185.426,188.091,192.592,196.592,200.586,203.247,207.333,210.994,215.08,216.998,220.915,225.001,227.561,231.577,235.905,240.534,244.62,247.281,251.199,253.86,255.778,260.279,264.679,268.67,272.355,276.768,279.43,283.347,287.433" svgx:width="0.4,0.32,0.48,0.32,0.23,0.4,0.32,0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.4,0.23,0.55,0.55,0.23,0.29,0.23,0.45,0.48,0.55,0.32,0.2,0.55,0.6,0.32,0.5,0.48,0.4,0.55,0.54,0.55,0.56,0.5,0.32,0.55,0.32,0.55,0.5,0.55,0.32,0.5,0.45,0.5,0.23,0.48,0.5,0.32,0.55,0.54,0.56,0.5,0.32,0.48,0.32,0.23,0.55,0.55,0.55,0.45,0.54,0.32,0.48,0.5,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">statistically significant. Areas under the receiver operating curves</text>
   <text y="676.574" x="56.523,62.419,66.5,69.165,73.165,76.422,80.106,84.018,85.85,89.574,93.997,95.924,99.836,102.501,106.582,111.078" svgx:width="0.73,0.5,0.32,0.5,0.55,0.45,0.48,0.23,0.45,0.54,0.23,0.48,0.32,0.5,0.56,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">were calculated.</text>
   <text y="685.589" x="56.523,61.019,65.099,68.427,72.923,74.923,77.667,80.901" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="685.589" x="86.06,91.556,95.972,99.972,103.295,107.711,112.039,116.455,120.951,123.527,127.527,132.007,135.27,139.766,143.598,146.174,148.006,152.006,156.422,158.998,162.19799999999998,165.43,167.678,172.006,176.334,178.894,182.212,186.54,188.85999999999999,192.19,196.27,200.35,204.43,207.724,210.884,214.46,217.036,221.036,225.036,229.452,233.452,237.948,240.18800000000002,243.497,249.329,253.329,255.905,259.905,263.17,267.17,271.586,274.162,278.49,280.322,282.154,286.154" svgx:width="0.69,0.55,0.5,0.55,0.55,0.54,0.55,0.56,0.32,0.5,0.56,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.28,0.54,0.54,0.32,0.55,0.54,0.29,0.55,0.51,0.51,0.51,0.55,0.4,0.45,0.32,0.5,0.5,0.55,0.5,0.56,0.28,0.55,0.73,0.5,0.32,0.5,0.55,0.5,0.55,0.32,0.54,0.23,0.23,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">One hundred patients (out of 783 screened) were enrolled</text>
   <text y="694.603" x="56.523,58.355,62.754999999999995,66.898,69.474,73.89,77.89,82.034,85.194,87.77,92.098,96.594,100.354,104.541,108.373,111.949,115.525,119.853,122.429,126.925,128.757,133.173,137.573,141.675,144.251,148.571,152.787,155.363,159.779,163.779,167.924,169.756,174.172,177.748,179.58,183.908,187.068,188.899,193.227,197.643,200.307,204.207,207.871,211.447,213.279,217.607,220.767,222.599,226.927,231.327,235.502,239.078,241.654,243.486,246.062,250.062,252.638,254.47,258.302,259.90200000000004,264.019,268.266,272.098,274.674,276.506,280.506,284.922,287.498" svgx:width="0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.48,0.45,0.45,0.54,0.32,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.32,0.55,0.5,0.55,0.23,0.55,0.45,0.23,0.54,0.4,0.23,0.54,0.55,0.33,0.5,0.46,0.45,0.23,0.54,0.4,0.23,0.54,0.55,0.55,0.45,0.32,0.23,0.32,0.5,0.32,0.23,0.48,0.2,0.55,0.53,0.48,0.32,0.23,0.5,0.55,0.32,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">in the study according to the inclusion/exclusion criteria. Patients</text>
   <text y="703.56" x="56.523,62.355,66.355,68.931,72.931,75.345,79.177,82.337,85.497,87.329,91.745,96.161,100.161,104.641,107.149,108.981,113.397,115.973,120.293,122.74,127.156,129.731,134.059,138.387,142.883,146.043,147.643,150.122,155.37,159.61,161.177,165.897,167.47,172.302,176.55,181.798,185.718,188.163,190.411,194.811,196.383,201.103,202.733,206.813,210.893,212.493,214.922,219.002,223.08200000000002,224.673,229.393,230.965,235.045,236.621,240.70100000000002,243.211,246.955,250.955,254.787,257.363,260.563,262.997,267.325,269.157,273.653,275.25300000000004,277.737,284.153,286.817" svgx:width="0.73,0.5,0.32,0.5,0.55,0.48,0.4,0.4,0.23,0.55,0.55,0.5,0.56,0.55,0.23,0.55,0.32,0.54,0.55,0.55,0.32,0.54,0.54,0.56,0.4,0.2,0.55,0.66,0.53,0.55,0.59,0.55,0.6,0.53,0.66,0.49,0.55,0.28,0.55,0.55,0.59,0.55,0.51,0.51,0.2,0.55,0.51,0.51,0.55,0.59,0.55,0.51,0.2,0.51,0.55,0.47,0.5,0.48,0.32,0.4,0.55,0.54,0.23,0.56,0.2,0.55,0.8,0.33,0.48" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">were assigned into groups: NP + ARDS (n = 55, 45 ± 5.1 years old, M/F</text>
   <text y="712.575" x="56.523,60.603,64.683,67.347,71.427,73.027,76.082,82.746,87.074,89.65,92.226,96.058,97.889,99.721,102.217,105.977,109.077,113.157,117.237,118.813,122.893,126.028,132.356,134.596,137.707,141.539,145.955,150.435,153.525,158.773,163.013,166.11,168.358,172.758,174.331,179.051,180.68,184.76,188.84,190.44,193.493,197.573,201.65300000000002,203.244,207.964,209.537,213.617,215.193,219.27300000000002,222.406,226.15,230.15,233.982,236.558,239.75799999999998,242.816,247.144,248.976,253.472,255.072,258.123,264.539,267.203,271.04299999999995,274.11,278.19,282.27,284.934,289.014" svgx:width="0.51,0.51,0.33,0.51,0.2,0.55,0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.28,0.55,0.48,0.55,0.56,0.55,0.66,0.53,0.55,0.28,0.55,0.55,0.59,0.55,0.51,0.51,0.2,0.55,0.51,0.51,0.55,0.59,0.55,0.51,0.2,0.51,0.55,0.47,0.5,0.48,0.32,0.4,0.55,0.54,0.23,0.56,0.2,0.55,0.8,0.33,0.48,0.55,0.51,0.51,0.33,0.51,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">50/5, mortality 29,0 %) and NP (n = 45, 42 ± 5.8 years old, M/F 41/4,</text>
   <text y="721.589" x="56.523,63.187,67.515,70.091,72.667,76.499,78.236,80.068,82.644,86.40400000000001,89.631,93.711,97.791,99.367,103.447,106.639,112.967,115.215,116.815,120.019,125.179,127.755,132.083,136.411,140.907,144.107,147.231,153.063,157.063,159.639,163.639,166.79,170.366,174.694,181.358,185.854,189.686,192.262,196.094,200.59,202.337,206.337,209.594,211.426,215.826,219.005,223.837,228.085,232.917,237.493,242.652,246.57199999999997,249.732,251.564,253.404,256.649,260.481,264.897,269.377,272.58,276.492,281.988,285.82" svgx:width="0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.28,0.2,0.55,0.64,0.32,0.54,0.54,0.56,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.45,0.54,0.83,0.56,0.48,0.32,0.48,0.56,0.23,0.5,0.55,0.23,0.55,0.55,0.6,0.53,0.6,0.57,0.64,0.49,0.55,0.23,0.23,0.55,0.48,0.55,0.56,0.55,0.49,0.69,0.48,0.6" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">mortality 26,6 %). Groups were comparable in APACHE II and SOFA</text>
   <text y="730.603" x="56.523,59.683,63.259,67.587,70.163,74.163,77.363,79.767,84.095,88.495,90.993,93.569,97.985,101.985,104.485,108.981,112.813,115.973,119.973,121.805,123.637,128.053,132.053,133.653,136.063,137.895,142.29500000000002,144.794,147.37,151.786,155.786,158.23,163.477,167.717,169.285,174.005,175.634,180.466,184.714,189.962,193.88199999999998,196.327,200.743,203.319,207.646,211.974,216.45399999999998,218.947,222.859,227.107,232.387,234.821,240.653,244.485,247.685,250.128,254.544,256.376,260.792,265.208,269.208,271.76800000000003,274.223,278.055,280.615,283.124,286.956,288.788" svgx:width="0.4,0.45,0.54,0.32,0.5,0.4,0.55,0.54,0.55,0.55,0.32,0.55,0.5,0.55,0.56,0.48,0.4,0.5,0.23,0.23,0.55,0.5,0.2,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.66,0.53,0.55,0.59,0.55,0.6,0.53,0.66,0.49,0.55,0.55,0.32,0.54,0.54,0.56,0.55,0.49,0.53,0.66,0.55,0.73,0.48,0.4,0.55,0.55,0.23,0.55,0.55,0.5,0.32,0.55,0.48,0.32,0.55,0.48,0.23,0.23" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">scores on the baseline. In the NP + ARDS group SPD was higher at all</text>
   <text y="95.362" x="304.78,309.276,313.604,315.436,319.852,322.427,325.627,329.384,331.96,336.376,340.208,344.608,348.433,350.265,354.66499999999996,358.524,361.1,365.516,369.516,373.32,378.568,382.808,386.643,391.059,393.635,397.963,402.291,406.787,408.387,412.212,416.46,418.292,422.124,425.284,431.948,435.78799999999995,439.538,443.45,447.698,452.97799999999995,456.773,461.101,465.501,469.359,473.855,477.687,481.447,485.233,489.313,490.903,495.62300000000005,497.196,501.276,505.355,509.435,511.011,515.091,518.909,523.325,527.741,530.405,537.069" svgx:width="0.56,0.54,0.23,0.55,0.32,0.4,0.55,0.32,0.55,0.48,0.55,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.66,0.53,0.55,0.55,0.32,0.54,0.54,0.56,0.2,0.55,0.53,0.23,0.48,0.4,0.83,0.48,0.55,0.49,0.53,0.66,0.55,0.54,0.55,0.55,0.56,0.48,0.47,0.55,0.51,0.55,0.59,0.55,0.51,0.51,0.51,0.2,0.51,0.55,0.55,0.55,0.33,0.83,0.23" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">points than in the NP group. Plasma SPD on day 0 &gt; 111.2 ng/ml</text>
   <text y="104.32" x="304.78,308.524,310.356,314.356,316.188,320.683,324.683,329.163,332.616,336.45599999999996,339.873,343.033,347.033,351.449,354.609,356.441,359.017,360.849,364.68,366.512,369.088,372.848,376.27,380.598,382.918,386.418,390.498,394.578,396.154,400.234,403.653,409.973,413.461,417.293,421.709,426.189,429.675,432.835,437.331,441.331,444.907,446.739,449.067,450.899,454.393,456.225,458.801,462.561,466.015,470.343,472.663,476.163,480.243,484.323,485.899,489.979,493.454,499.774,503.205,505.453,510.285,515.445,520.005,523.501,527.581,529.157,533.237,537.317" svgx:width="0.47,0.23,0.5,0.23,0.56,0.5,0.56,0.55,0.48,0.55,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.48,0.55,0.56,0.55,0.4,0.56,0.5,0.45,0.23,0.29,0.23,0.45,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.28,0.6,0.64,0.57,0.55,0.51,0.2,0.51,0.51,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">yielded a sensitivity of 68.2 % and specificity of 92.3 % (AUC 0.85;</text>
   <text y="113.334" x="304.78,308.86,312.94,315.948,322.268,325.303,329.879,331.719,334.771,338.85,340.426,344.506,348.586,352.666,355.082,359.162,360.738,364.818,368.786,372.866,374.466,377.516,381.99600000000004,383.583,388.30300000000005,389.875,393.955,395.531,399.611,403.691,407.771,411.851,414.091,417.088,419.416,423.744,426.30400000000003,429.333,433.829,435.661,439.493,443.909,448.325,452.653,455.813,457.645,462.061,466.46099999999996,469.472,474.304,478.552,483.8,487.72,490.675,492.507,496.907,499.973,505.22,509.468,511.06800000000004,514.032,518.832,521.913,525.489,529.817,536.481" svgx:width="0.51,0.51,0.55,0.79,0.55,0.57,0.23,0.55,0.51,0.2,0.51,0.51,0.51,0.3,0.51,0.2,0.51,0.51,0.51,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.51,0.28,0.55,0.29,0.54,0.32,0.55,0.56,0.23,0.48,0.55,0.55,0.54,0.4,0.23,0.55,0.55,0.55,0.6,0.53,0.66,0.49,0.55,0.23,0.55,0.55,0.66,0.53,0.2,0.55,0.6,0.55,0.45,0.54,0.83,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">95 % CI 0.684-0.945; p &lt; 0.0001) for diagnosing ARDS in NP. A com-</text>
   <text y="122.348" x="304.78,309.276,311.108,315.108,318.788,321.844,326.092,331.588,336.148,339.249,343.081,347.497,351.329,353.161,356.905,360.065,361.897,365.097,368.162,370.41,374.322,378.57,385.34,390.06,391.633,395.881,398.545,402.385,405.466,408.042,411.874,414.45,416.282,420.602,423.721,428.465,432.545,436.625,440.705,442.259,446.97900000000004,448.552,452.464,456.88,460.624,467.368,469.20799999999997,472.306,477.05,481.13,482.706,486.786,489.881,496.545,498.377,501.041,504.785,509.201,511.44100000000003,514.486,518.23,520.062,524.062,525.894,530.39,534.39" svgx:width="0.56,0.23,0.5,0.46,0.55,0.53,0.69,0.57,0.55,0.48,0.55,0.48,0.23,0.47,0.4,0.23,0.4,0.55,0.28,0.49,0.53,0.66,0.59,0.55,0.53,0.33,0.48,0.55,0.32,0.48,0.32,0.23,0.54,0.55,0.59,0.51,0.51,0.51,0.55,0.59,0.55,0.49,0.55,0.47,0.84,0.23,0.55,0.59,0.51,0.2,0.51,0.55,0.83,0.23,0.33,0.47,0.55,0.28,0.55,0.47,0.23,0.5,0.23,0.56,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">plex ROC analysis (SPD+ P/F ratio &lt;280 + EVLWI &gt;8.3 ml/kg) yielded</text>
   <text y="131.363" x="304.78,308.61999999999995,312.207,316.703,320.703,323.279,325.855,329.855,332.415,336.074,340.57,342.402,346.234,350.65,355.066,359.394,362.437,365.012,366.844,370.444,374.059,377.891,381.467,385.043,389.371,391.947,395.778,399.354,403.114,406.714,411.041,413.361,416.975,420.887,425.135,430.383,431.983,435.57,439.146,443.474,446.05,450.378,452.706,455.026,458.644,463.388,467.468,471.548,473.124,477.204,480.811,485.227,489.643,492.307,498.971,500.803,502.403,505.983,509.143,513.143,517.559,520.719,522.551,525.127,526.958,530.701,532.533,535.109" svgx:width="0.48,0.55,0.56,0.5,0.32,0.32,0.5,0.32,0.55,0.56,0.23,0.48,0.55,0.55,0.54,0.4,0.32,0.23,0.45,0.55,0.48,0.45,0.45,0.54,0.32,0.48,0.45,0.47,0.55,0.54,0.29,0.55,0.49,0.53,0.66,0.2,0.55,0.45,0.54,0.32,0.54,0.29,0.29,0.55,0.59,0.51,0.51,0.2,0.51,0.55,0.55,0.55,0.33,0.83,0.23,0.2,0.55,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.23,0.32,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">a better diagnostic accuracy of SPD: cutoff &gt;93.7 ng/ml, sensitivity</text>
   <text y="140.32" x="304.78,308.86,312.94,314.516,318.596,323.148,329.476,331.076,335.564,338.724,343.22,347.22,350.796,352.628,354.956,356.788,360.364,362.196,364.772,368.532,373.038,377.118,381.198,385.278,386.854,390.93399999999997,395.488,401.808,406.373,408.621,413.453,418.613,423.173,427.689,431.769,433.345,437.425,441.505,443.105,447.645,451.725,455.805,460.344,466.664,471.229,475.805,477.645,482.227,486.307,487.883,491.963,496.043,500.123,502.539,506.619,508.195,512.275,516.243,520.323,521.923,526.504,530.984,532.571" svgx:width="0.51,0.51,0.2,0.51,0.55,0.79,0.2,0.55,0.4,0.56,0.5,0.45,0.23,0.29,0.23,0.45,0.23,0.32,0.47,0.55,0.51,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.28,0.6,0.64,0.57,0.55,0.51,0.2,0.51,0.51,0.2,0.55,0.51,0.51,0.55,0.79,0.55,0.57,0.23,0.55,0.51,0.2,0.51,0.51,0.51,0.3,0.51,0.2,0.51,0.51,0.51,0.2,0.55,0.56,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">81.0 %, specificity 100.0 % (AUC 0.96; 95 % CI 0.817-0.998; p &lt;</text>
   <text y="149.334" x="304.78,308.86,310.436,314.516,318.596,322.676,326.755,329.003,330.603,333.636,337.548,341.796,346.596,349.68,354.008,358.40799999999996,361.529,366.025,369.857,373.617,376.665,380.745,383.865,385.697,388.897,391.972,396.388,400.716,403.276,406.372,408.204,412.62,414.948,419.276,421.852,428.516,432.348,434.924,436.756,440.501,444.501,447.588,449.916,454.243,456.803,459.947,464.779,469.026,474.274,478.194,481.263,485.759,487.591,491.423,495.839,500.255,504.583,507.743,509.575,512.775,515.732,517.98,521.892,526.14,530.9399999999999,532.514" svgx:width="0.51,0.2,0.51,0.51,0.51,0.51,0.28,0.2,0.55,0.49,0.53,0.6,0.55,0.54,0.55,0.55,0.56,0.48,0.47,0.55,0.51,0.55,0.23,0.4,0.55,0.55,0.54,0.32,0.55,0.23,0.55,0.29,0.54,0.32,0.83,0.48,0.32,0.23,0.48,0.5,0.55,0.29,0.54,0.32,0.55,0.6,0.53,0.66,0.49,0.55,0.56,0.23,0.48,0.55,0.55,0.54,0.4,0.23,0.4,0.55,0.28,0.49,0.53,0.6,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">0.0001). SPA on day 0 is not informative for ARDS diagnosis (SPA &gt;</text>
   <text y="158.349" x="304.78,308.86,312.94,314.516,318.596,320.994,325.41,329.826,332.49,339.154,340.986,342.586,344.975,348.135,352.135,356.551,359.711,361.543,364.119,365.951,369.783,371.615,374.191,377.95099999999996,380.352,384.68,387.0,389.479,393.559,397.639,399.215,403.29499999999996,405.694,412.022,413.622,416.069,419.229,423.725,427.725,431.301,433.133,435.461,437.292,440.787,442.619,445.195,448.955,451.388,455.716,458.036,460.516,464.596,468.676,470.252,474.332,476.787,483.115,484.71500000000003,487.105,491.937,497.097,501.657,504.113,508.193,509.769,513.849,517.929,519.529,521.971,526.051,530.1310000000001,532.573" svgx:width="0.51,0.51,0.2,0.51,0.55,0.55,0.55,0.33,0.83,0.23,0.2,0.55,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.2,0.55,0.4,0.56,0.5,0.45,0.23,0.29,0.23,0.45,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.2,0.55,0.6,0.64,0.57,0.55,0.51,0.2,0.51,0.51,0.2,0.55,0.51,0.51,0.55,0.79" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">36.2 ng/ml, sensitivity of 51.2 %, specificity of 92.3 %, AUC 0.61; 95 %</text>
   <text y="167.363" x="304.78,309.356,311.19599999999997,313.794,317.874,319.45,323.53,327.61,331.69,334.106,338.186,339.762,343.842,347.922,352.002,353.60200000000003,356.144,360.624,362.21,366.93,368.503,372.583,374.159,378.239,382.319,386.399,390.479,392.727,394.327,396.906,401.154,402.986,406.818,409.978,416.642,420.48199999999997,423.042,426.953,431.201,436.00100000000003,438.632,444.464,448.296,451.496,454.052,457.212,459.044,463.46,467.876,469.708,472.036,473.868,477.444,481.276,485.692,488.182,490.013,493.77299999999997,496.402,498.234,502.562,508.394,512.394,514.954,517.548,519.38,523.78,526.392,529.552,533.88,536.456" svgx:width="0.57,0.23,0.55,0.51,0.2,0.51,0.51,0.51,0.3,0.51,0.2,0.51,0.51,0.51,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.51,0.28,0.2,0.55,0.53,0.23,0.48,0.4,0.83,0.48,0.55,0.49,0.53,0.6,0.55,0.73,0.48,0.4,0.55,0.4,0.23,0.55,0.55,0.23,0.29,0.23,0.45,0.48,0.55,0.32,0.23,0.47,0.55,0.23,0.54,0.73,0.5,0.32,0.55,0.23,0.55,0.55,0.4,0.54,0.32,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">CI 0.474-0.745; p &lt; 0.1168). Plasma SPA was significantly lower in sur-</text>
   <text y="176.32" x="304.78,308.612,310.444,314.276,318.275,322.755,327.683,331.515,335.515,338.091,341.251,345.579,348.779,353.705,358.201,360.033,364.033,368.51300000000003,373.492,377.987,381.819,384.395,386.227,390.227,394.643,397.219,400.419,405.296,411.128,412.96,415.536,419.936,424.912,429.744,433.992,439.24,443.151,444.75100000000003,449.687,453.935,455.767,459.598,462.758,469.422,473.262,478.203,482.115,486.363,491.163,496.175,500.503,504.90299999999996,509.838,514.334,518.166,521.926,526.902,530.9820000000001,532.572" svgx:width="0.48,0.23,0.48,0.5,0.56,0.55,0.48,0.5,0.32,0.4,0.54,0.4,0.55,0.56,0.23,0.5,0.56,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.6,0.53,0.66,0.49,0.2,0.55,0.53,0.23,0.48,0.4,0.83,0.48,0.55,0.49,0.53,0.6,0.55,0.54,0.55,0.55,0.56,0.48,0.47,0.55,0.51,0.55,0.59" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">vived versus died patients with ARDS. Plasma SPA on day 0 &gt;</text>
   <text y="185.335" x="304.78,309.524,313.604,317.684,319.26,323.34,325.699,330.115,334.531,337.195,343.859,345.69899999999996,348.094,351.838,353.67,357.669,359.501,363.997,367.997,372.47700000000003,374.852,378.69199999999995,381.088,384.248,388.248,392.664,395.824,397.656,400.232,402.064,405.896,407.728,410.304,414.06399999999996,416.408,420.736,423.056,425.479,429.559,433.639,435.215,439.29499999999996,441.75,448.07,450.48,454.312,458.728,463.208,465.617,468.777,473.273,477.273,480.849,482.681,485.009,486.841,490.335,492.167,494.743,498.503,500.936,505.264,507.584,510.007,514.087,518.167,519.702,524.422,526.051,530.1310000000001,532.514" svgx:width="0.59,0.51,0.51,0.2,0.51,0.55,0.55,0.55,0.33,0.83,0.23,0.55,0.47,0.23,0.5,0.23,0.56,0.5,0.56,0.55,0.48,0.55,0.4,0.5,0.55,0.4,0.23,0.32,0.23,0.48,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.2,0.51,0.55,0.79,0.55,0.48,0.55,0.56,0.55,0.4,0.56,0.5,0.45,0.23,0.29,0.23,0.45,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.51,0.51,0.55,0.59,0.55,0.51,0.55,0.79" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">=18,6 ng/ml yielded a sensitivity of 88,9 % and specificity of 72 &gt; 7 %</text>
   <text y="194.349" x="304.78,307.108,311.436,313.996,317.365,321.861,324.437,328.437,332.933,334.765,338.341,340.917,342.65,346.978,351.378,354.726,359.054,361.37399999999997,364.76,371.424,375.752,378.328,380.904,384.736,386.568,388.4,390.896,394.656,397.982,399.814,404.214,407.563,412.395,416.643,421.891,425.81100000000004,429.107,433.603,437.435,440.011,441.843,445.843,450.259,452.835,456.03499999999997,459.324,463.652,468.05199999999996,471.4,475.896,479.728,483.488,486.764,490.844,493.26,497.34,500.653,504.981,507.301,510.687,512.519,517.095,522.215,525.598,528.758,531.334,535.166" svgx:width="0.29,0.54,0.32,0.55,0.56,0.32,0.5,0.56,0.23,0.45,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.83,0.54,0.32,0.32,0.48,0.23,0.23,0.32,0.47,0.55,0.23,0.55,0.55,0.6,0.53,0.66,0.49,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.54,0.55,0.55,0.56,0.48,0.47,0.55,0.51,0.3,0.51,0.55,0.54,0.29,0.55,0.23,0.57,0.64,0.55,0.4,0.32,0.48,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">for prediction of mortality in ARDS patients on day 5-6 of ICU stay</text>
   <text y="203.363" x="304.78,307.028,311.86,317.02,321.58,323.942,328.022,329.598,333.678,337.758,339.358,341.687,345.766,349.846,352.231,358.551,360.961,365.537,367.37699999999995,369.749,373.829,375.405,379.484,383.564,387.644,390.06,394.14,395.716,399.796,403.876,407.956,409.55600000000004,411.871,416.351,417.938,422.658,424.23,428.31,429.886,433.966,438.046,442.126,446.206,448.454" svgx:width="0.28,0.6,0.64,0.57,0.55,0.51,0.2,0.51,0.51,0.2,0.55,0.51,0.51,0.55,0.79,0.55,0.57,0.23,0.55,0.51,0.2,0.51,0.51,0.51,0.3,0.51,0.2,0.51,0.51,0.51,0.2,0.55,0.56,0.55,0.59,0.55,0.51,0.2,0.51,0.51,0.51,0.51,0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(AUC 0.86; 95 % CI 0.685-0.962; p &lt; 0,0001).</text>
   <text y="212.321" x="304.78,309.444,313.94,318.436,322.011,324.011,328.507,331.835,333.835,338.229,342.725,346.053" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="212.321" x="351.211,355.123,359.539,363.867,367.027,368.627,371.96,373.792,378.19199999999995,381.542,385.374,389.87,394.366,398.694,405.358,407.19,411.606,415.331,417.171,420.49,423.65,427.65,432.146,435.306,437.138,440.33799999999997,443.621,448.117,451.949,454.525,456.357,460.357,464.773,467.349,470.549,473.838,479.67,481.502,484.078,488.47799999999995,491.81,497.058,501.298,504.623,508.455,512.871,517.351,520.667,525.499,529.746,534.994" svgx:width="0.49,0.55,0.54,0.4,0.2,0.55,0.23,0.55,0.55,0.48,0.56,0.56,0.54,0.83,0.23,0.55,0.48,0.23,0.55,0.4,0.5,0.56,0.4,0.23,0.4,0.55,0.56,0.48,0.32,0.23,0.5,0.55,0.32,0.4,0.55,0.73,0.23,0.32,0.55,0.55,0.66,0.53,0.55,0.48,0.55,0.56,0.55,0.6,0.53,0.66,0.49" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Thus, in abdominal sepsis patients with NP and ARDS</text>
   <text y="221.335" x="304.78,309.196,313.196,319.036,321.391,328.055,332.383,334.215,338.214,341.79,346.118,347.95,351.782,354.342,356.71,361.206,363.038,367.366,374.03,377.862,380.438,384.182,388.182,390.669,393.86899999999997,396.282,399.858,403.69,408.09,410.512,415.008,419.008,421.396,425.724,428.884,432.884,437.36400000000003,439.765,442.093,446.421,448.981,451.387,456.219,460.467,465.715,469.635,472.024,476.52,478.352,482.184,486.6,491.016,495.344,498.504,500.335,503.53499999999997,505.87,508.118,512.03,516.278,521.526,523.766,526.166,529.997,534.413" svgx:width="0.55,0.5,0.73,0.55,0.83,0.54,0.23,0.5,0.45,0.54,0.23,0.48,0.32,0.55,0.56,0.23,0.54,0.83,0.48,0.32,0.47,0.5,0.32,0.4,0.55,0.45,0.48,0.55,0.55,0.56,0.5,0.55,0.54,0.4,0.5,0.56,0.55,0.29,0.54,0.32,0.55,0.6,0.53,0.66,0.49,0.55,0.56,0.23,0.48,0.55,0.55,0.54,0.4,0.23,0.4,0.55,0.28,0.49,0.53,0.66,0.28,0.55,0.48,0.55,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">new molecular biomarkers can be used for ARDS diagnosis (SPD) and</text>
   <text y="230.349" x="304.78,309.276,311.852,316.18,320.595,325.011,329.339,332.499,334.997,336.829,339.157,340.989,344.565,348.397,350.973,352.805,357.133,361.53299999999996,363.91,368.238,370.558,372.924,377.252,381.58,384.156,387.732,392.06,398.724,402.724,405.924,408.244,410.492,414.404,418.652,423.484,425.732" svgx:width="0.56,0.32,0.54,0.55,0.55,0.54,0.4,0.32,0.23,0.29,0.23,0.45,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.54,0.54,0.32,0.45,0.54,0.83,0.5,0.4,0.55,0.28,0.49,0.53,0.6,0.28,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">prognostification of outcomes (SPA).</text>
   <text y="251.326" x="304.78,309.356,313.772,318.188" svgx:width="0.57,0.55,0.55,0.55" style="fill:rgb(235,103,59);font-family:AdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;">P268</text>
   <text y="260.34" x="304.78,308.94,310.94,315.516,320.012,322.732,325.132,327.212,331.708,336.204,339.78,342.524,344.524,349.02,353.422,355.237,358.59700000000004,360.963,365.627,368.459,372.955,375.699,379.779,381.779,386.275,389.635,391.974,395.55,397.55,401.55,406.046,410.622,412.622,417.10200000000003,419.469,421.965,426.205,428.597,432.597,437.093,441.653,444.018,446.85,450.93,455.506,460.002,462.002,466.002,468.746,470.746,475.242,479.72200000000004,482.059,486.723,490.723,493.114,495.858,500.354,502.834,505.19,507.19" svgx:width="0.52,0.25,0.57,0.56,0.34,0.55,0.26,0.56,0.56,0.45,0.34,0.25,0.56,0.56,0.23,0.42,0.55,0.58,0.35,0.56,0.34,0.51,0.25,0.56,0.42,0.55,0.45,0.25,0.5,0.56,0.57,0.25,0.56,0.55,0.31,0.53,0.55,0.5,0.56,0.57,0.55,0.35,0.51,0.57,0.56,0.25,0.5,0.34,0.25,0.56,0.56,0.55,0.58,0.5,0.55,0.34,0.56,0.31,0.55,0.25,0.56" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Tight junction’s proteins claudin -5 and regulation by tnf in</text>
   <text y="269.354" x="304.78,308.86,312.772,317.436,321.516,324.348,326.348,333.092,337.172,341.574,344.318,348.318,350.318,352.686,359.43,363.926,366.758,368.758,373.254,377.334,379.672,381.672,386.168,390.664,395.224,397.587,399.587,404.083,406.163,410.659,413.491,417.491,419.868,426.612,431.108,435.684,439.764,441.764,444.132,448.628,451.108,453.487,457.487,459.487,461.487,464.15,468.15,470.982,475.558" svgx:width="0.51,0.49,0.58,0.51,0.35,0.25,0.84,0.51,0.56,0.34,0.5,0.25,0.55,0.84,0.56,0.35,0.25,0.56,0.51,0.55,0.25,0.56,0.56,0.57,0.55,0.25,0.56,0.26,0.56,0.35,0.5,0.55,0.84,0.56,0.57,0.51,0.25,0.55,0.56,0.31,0.55,0.5,0.25,0.25,0.33,0.5,0.35,0.57,0.42" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">experimental murine lung injury model of ali/ards</text>
   <text y="278.312" x="304.78,308.78,310.14,312.491,316.403,319.979,322.307,325.883,329.459,333.035,337.283" svgx:width="0.5,0.17,0.55,0.49,0.45,0.29,0.45,0.45,0.45,0.53,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">V. Karavana</text>
   <text y="274.791" x="340.838" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="278.306" x="343.672,345.03200000000004,347.414,351.91,353.27000000000004,355.635,360.547,362.211,365.706,369.954,374.202" svgx:width="0.17,0.55,0.56,0.17,0.55,0.61,0.21,0.44,0.53,0.53,0.36" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, C. Glynos</text>
   <text y="274.791" x="377.065" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="278.306" x="379.956,381.31600000000003,383.641,388.305,389.665,392.031,396.695,399.607,401.271,407.767,411.343,414.671,418.919" svgx:width="0.17,0.55,0.58,0.17,0.55,0.58,0.36,0.21,0.81,0.45,0.42,0.53,0.36" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, A. Asimakos</text>
   <text y="274.791" x="421.795" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="278.306" x="424.63,425.99,428.371,432.283,433.64300000000003,436.025,440.025,443.601,447.929,452.257,455.833" svgx:width="0.17,0.55,0.49,0.17,0.55,0.5,0.45,0.54,0.54,0.45,0.36" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, K. Pappas</text>
   <text y="274.791" x="458.702" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="278.306" x="461.594,462.954,465.278,469.774,471.134,473.499,477.499,479.827,483.659,486.075,488.491,492.739" svgx:width="0.17,0.55,0.56,0.17,0.55,0.5,0.29,0.48,0.3,0.3,0.53,0.52" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, C. Vrettou</text>
   <text y="274.791" x="499.238" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="278.306" x="502.129" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">,</text>
   <text y="287.32" x="304.782,310.942,312.302,314.647,320.806,324.382,328.71,332.038,336.286" svgx:width="0.77,0.17,0.55,0.77,0.45,0.54,0.42,0.53,0.52" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">M. Magkou</text>
   <text y="283.805" x="342.822" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="287.32" x="345.657,347.017,349.398,353.062,354.422,356.768,358.432,361.344,364.84,369.088,372.664,375.992" svgx:width="0.17,0.55,0.46,0.17,0.55,0.21,0.36,0.44,0.53,0.45,0.42,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, E. Ischaki</text>
   <text y="283.805" x="377.631" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="287.32" x="380.523,381.88300000000004,384.208,389.119,390.47900000000004,392.882,396.546,398.962,402.538,404.954,409.202,413.45,417.777,422.025,426.185,427.748,431.996" svgx:width="0.17,0.55,0.61,0.17,0.55,0.46,0.3,0.45,0.3,0.53,0.53,0.54,0.53,0.52,0.21,0.53,0.36" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, G. Stathopoulos</text>
   <text y="283.805" x="434.891" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="287.32" x="437.783,439.14300000000003,441.524,445.188,446.548,448.894,453.142,456.718,460.046,463.542,467.79,470.206,474.454,476.118,480.366,484.498" svgx:width="0.17,0.55,0.46,0.17,0.55,0.53,0.45,0.42,0.44,0.53,0.3,0.53,0.21,0.53,0.53,0.36" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, S. Zakynthinos</text>
   <text y="283.805" x="487.446" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="292.762" x="304.781" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="296.334" x="307.616,312.528,316.36,320.608,322.935,327.263,331.10299999999995,333.467,337.467,338.827,341.178,344.754,346.418,349.993,353.569,357.817,362.065,364.945,367.313,370.889,375.137,379.457,381.884,388.043,391.619,393.947,395.611,399.187,403.435,405.851,410.003,411.683,414.085,417.749,419.413,425.909,430.156,434.31600000000003,436.648,440.224,443.8,448.128,452.376,454.704,458.28,460.696,464.944,467.272,468.936,472.768,475.68,477.04,479.338,484.002,486.418,490.666,494.498,498.746,501.658,503.01800000000003,505.36,510.272,512.6,516.432,520.264,523.76,527.592" svgx:width="0.61,0.48,0.53,0.29,0.54,0.48,0.55,0.5,0.17,0.55,0.45,0.21,0.45,0.45,0.53,0.53,0.36,0.55,0.45,0.53,0.54,0.55,0.77,0.45,0.29,0.21,0.45,0.53,0.3,0.53,0.21,0.55,0.46,0.21,0.81,0.53,0.52,0.55,0.45,0.45,0.54,0.53,0.29,0.45,0.3,0.53,0.29,0.21,0.48,0.36,0.17,0.55,0.58,0.3,0.53,0.48,0.53,0.36,0.17,0.55,0.61,0.29,0.48,0.48,0.44,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">George P. Livanos and Marianthi Simou Laboratories, Athens, Greece;</text>
   <text y="301.776" x="304.781" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="305.348" x="307.616,312.616,316.864,318.528,322.104,325.935,328.263,331.175,332.839,335.255,338.775,341.121,345.369,347.449,349.795,353.795,357.371,359.787,362.115,365.691,368.603,369.963,372.302,376.302,377.966,382.214,383.574,385.965,390.629,394.125,398.373,401.949,403.613,407.189,408.54900000000004,410.853,415.765,418.093,421.925,425.757,429.253" svgx:width="0.63,0.53,0.21,0.45,0.48,0.29,0.36,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.5,0.45,0.3,0.29,0.45,0.36,0.17,0.55,0.5,0.21,0.53,0.17,0.55,0.58,0.44,0.53,0.45,0.21,0.45,0.17,0.55,0.61,0.29,0.48,0.48,0.44,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">University of Patras, Rio, Achaia, Greece</text>
   <text y="314.306" x="304.781,308.816,310.952,312.449,314.661,316.158,319.243,323.043,324.64300000000003,326.778,330.813,334.613,336.812" svgx:width="0.53,0.28,0.2,0.29,0.2,0.41,0.5,0.2,0.55,0.53,0.5,0.28,0.42" style="fill:rgb(19,20,19);font-family:AdvTT1b53b5fb.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="314.306" x="342.255,345.895,349.536,353.176,356.882" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">2016,</text>
   <text y="314.306" x="360.397,364.433,368.468,370.68,374.627,378.898,383.328,387.759,389.759,391.975,396.01,398.222" svgx:width="0.53,0.53,0.29,0.51,0.56,0.58,0.58,0.25,0.55,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">20(Suppl 2):</text>
   <text y="314.306" x="399.969,403.769,407.409,411.049" svgx:width="0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">P268</text>
   <text y="332.334" x="304.781,306.861,311.357,314.101,316.933,321.429,326.005,330.501,334.077,336.821,338.74,343.236,347.732" svgx:width="0.26,0.56,0.34,0.35,0.56,0.57,0.56,0.45,0.34,0.25,0.56,0.56,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Introduction:</text>
   <text y="332.334" x="353.196,358.028,361.604,365.932,368.508,372.508,376.1,379.844,384.172,388.588,392.988,396.623,398.455,402.871,404.783,409.111,411.687,415.447,419.017,422.849,427.265,431.745,435.402,439.234,442.81,447.138,449.714,453.714,457.285,459.861,463.861,467.021,471.517,473.349,475.925,479.757,482.333,486.661,489.237,492.997,496.574,501.07,502.902,506.062,508.638,511.214,515.213,518.373,521.5730000000001,525.147,528.307,532.051,536.467" svgx:width="0.6,0.45,0.54,0.32,0.5,0.55,0.47,0.54,0.55,0.55,0.55,0.23,0.55,0.24,0.54,0.32,0.47,0.55,0.48,0.55,0.56,0.55,0.48,0.45,0.54,0.32,0.5,0.55,0.32,0.5,0.4,0.56,0.23,0.32,0.48,0.32,0.54,0.32,0.47,0.55,0.56,0.23,0.4,0.32,0.32,0.5,0.4,0.4,0.55,0.4,0.47,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Acute Lung Injury and acute respiratory distress syn-</text>
   <text y="341.348" x="304.781,309.277,311.853,316.181,322.845,326.845,329.216,331.464,336.296,340.04,341.872,344.536,349.368,353.616,358.864,362.775,365.015,367.371,369.203,372.40299999999996,374.798,378.374,382.79,386.622,389.198,393.03,396.605,399.181,403.181,405.757,407.509,410.925,414.925,419.40500000000003,421.852,426.348,430.108,432.511,435.087,436.919,441.334,445.75,448.31,450.709,452.621,456.949,461.365,464.941,467.517,469.349,473.676,478.034,479.111,482.311,484.724,486.972,490.884,493.794,494.871,498.031,500.271,502.695,507.19,511.022,513.598,516.174,518.006,522.006,524.5659999999999,526.959,531.455,533.287,536.447" svgx:width="0.56,0.32,0.54,0.83,0.5,0.55,0.28,0.6,0.47,0.23,0.33,0.6,0.53,0.66,0.49,0.28,0.55,0.23,0.4,0.55,0.45,0.55,0.48,0.32,0.48,0.45,0.32,0.5,0.32,0.23,0.43,0.5,0.56,0.55,0.56,0.47,0.55,0.32,0.23,0.55,0.55,0.32,0.55,0.24,0.54,0.55,0.45,0.32,0.23,0.54,0.55,0.2,0.4,0.55,0.28,0.49,0.36,0.2,0.4,0.28,0.55,0.56,0.48,0.32,0.32,0.23,0.5,0.32,0.55,0.56,0.23,0.4,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">drome (ALI/ARDS) is characterized by tight junction’s (TJ’s) barrier dis-</text>
   <text y="350.306" x="304.78,307.356,311.684,316.18,318.756,320.588,324.916,329.316,333.127,336.959,341.375,345.855,349.738,353.314,357.73,361.562,365.978,370.394,374.286,377.486,381.315,383.147,387.54699999999997,391.406,393.982,398.398,402.398,406.26,409.836,414.164,420.828,425.323,429.651,432.811,434.643,437.219,438.971,443.299,447.69899999999996,451.557,455.389,459.805,464.285,468.168,470.0,474.416,476.992,480.992,485.408,487.983,489.815,492.391,496.151,499.916,504.244,506.564,510.461,515.037,516.869,520.701,525.029,529.525,531.357,535.773" svgx:width="0.32,0.54,0.56,0.32,0.23,0.54,0.55,0.55,0.48,0.55,0.56,0.55,0.45,0.55,0.48,0.55,0.55,0.5,0.4,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.45,0.54,0.83,0.56,0.54,0.4,0.23,0.32,0.23,0.54,0.55,0.55,0.48,0.55,0.56,0.55,0.23,0.55,0.32,0.5,0.55,0.32,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.57,0.23,0.48,0.54,0.56,0.23,0.55,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ruption and changes in the composition and integrity of Claudins</text>
   <text y="359.32" x="304.78,307.028,311.604,315.348,320.596,325.844,328.084,330.519,336.351,340.767,342.599,346.175,350.575,352.969,356.801,359.377,363.377,365.839,369.415,373.743,380.406,384.902,389.23,393.646,397.646,401.952,404.528,407.728,410.172,414.5,416.82,419.3,423.212,426.103,427.179,430.339,431.939,434.379,438.955,442.699,447.947,453.195,457.275,459.665,461.497,464.697,467.148,471.564,473.396,477.812,482.228,484.06,487.82,490.222,494.222,497.886,502.382,504.958,508.958,512.118,515.278,519.277,523.7570000000001,526.165,529.997,534.413" svgx:width="0.28,0.57,0.47,0.66,0.66,0.28,0.55,0.73,0.55,0.23,0.45,0.55,0.55,0.48,0.32,0.5,0.55,0.45,0.54,0.83,0.56,0.54,0.55,0.5,0.55,0.32,0.4,0.55,0.54,0.29,0.55,0.49,0.36,0.2,0.4,0.2,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.23,0.4,0.55,0.55,0.23,0.55,0.55,0.23,0.47,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.5,0.56,0.55,0.48,0.55,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">(CLDN) which are components of TJ’s. CLDN5 is highly expressed and</text>
   <text y="368.334" x="304.78,308.612,312.94,317.356,324.02,328.02,332.333,334.89300000000003,338.172,342.668,346.668,349.244,355.908,359.907,363.739,368.235,370.067,371.899,373.731,376.213,379.973,383.243,385.075,389.47499999999997,392.711,394.543,398.871,403.287,407.68699999999995,410.909,415.405,419.237,421.813,425.813,430.229,433.805,438.221,441.965,448.629,452.461,454.06100000000004,457.227,461.059,462.891,465.467,469.883,474.211,478.539,482.955,487.35499999999996,490.563,493.139,497.554,501.554,504.793,507.369,511.369,515.785,520.113,521.945,525.776,528.352,530.184,534.512" svgx:width="0.48,0.54,0.55,0.83,0.5,0.55,0.32,0.55,0.56,0.5,0.32,0.83,0.5,0.48,0.56,0.23,0.23,0.23,0.32,0.47,0.55,0.23,0.55,0.55,0.23,0.54,0.55,0.55,0.55,0.56,0.48,0.32,0.5,0.55,0.45,0.55,0.47,0.83,0.48,0.2,0.55,0.48,0.23,0.32,0.55,0.54,0.54,0.55,0.55,0.55,0.32,0.55,0.5,0.55,0.32,0.5,0.55,0.54,0.23,0.48,0.32,0.23,0.54,0.55" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">augment permeability in lung parenchyma, although the regulation</text>
   <text y="377.348" x="304.78,309.276,313.036,318.046,319.878,324.294,326.622,328.454,332.286,338.95,345.614,349.446,352.022,356.257,358.833,362.593,367.652,370.812,373.388,375.22,381.884,386.212,388.044,389.88399999999996,394.921,397.497,401.497,408.161,411.993,413.825,418.241,421.441,426.443,430.443,432.274,436.602,439.762,441.594,445.426,449.426,451.026,455.98,459.892,464.308,466.14,469.34,474.348,477.508,480.084,484.412,488.908,492.668,497.706,501.538,503.37,510.033,513.2330000000001,518.229,520.805,525.125,530.248,532.08,536.496" svgx:width="0.56,0.47,0.55,0.23,0.55,0.29,0.23,0.48,0.83,0.83,0.48,0.32,0.54,0.32,0.47,0.55,0.4,0.32,0.23,0.83,0.54,0.23,0.23,0.55,0.32,0.5,0.83,0.48,0.23,0.55,0.4,0.55,0.5,0.23,0.54,0.4,0.23,0.48,0.5,0.2,0.55,0.49,0.55,0.23,0.4,0.55,0.4,0.32,0.54,0.56,0.47,0.55,0.48,0.23,0.83,0.4,0.55,0.32,0.54,0.55,0.23,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">by inflammatory stimuli remains elusive. This study aims to in-</text>
   <text y="386.306" x="304.78,308.612,312.612,315.772,318.348,320.18,324.596,328.428,330.916,334.916,338.456,343.032,346.776,352.024,357.271,361.351,364.875,368.875,372.538,377.034,379.61,383.61,386.77,389.93,391.762,395.999,400.399,403.992,407.824,412.24,416.72,420.263,422.839,426.839,431.255,435.583,437.415,441.247,443.823,445.549,449.877,454.277,457.851,462.347,466.10699999999997,469.643,473.555,478.803,482.635,484.235,487.728,489.56,493.96,497.479,501.223,505.471,509.383,511.799,513.631,518.047,522.543,526.871,530.361,534.361" svgx:width="0.48,0.5,0.4,0.32,0.23,0.55,0.48,0.32,0.5,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.48,0.55,0.56,0.55,0.32,0.5,0.55,0.54,0.23,0.48,0.32,0.23,0.54,0.55,0.55,0.56,0.47,0.55,0.49,0.66,0.48,0.2,0.55,0.23,0.55,0.55,0.47,0.53,0.49,0.3,0.23,0.55,0.56,0.54,0.45,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">vestigate CLDN5 expression and regulation by TNF, in LPS-induced</text>
   <text y="395.32" x="304.78,309.612,313.356,315.188,317.852,322.684,326.932,332.18,336.1,338.399,340.231,344.631,347.016,353.68,355.512,359.088,363.088" svgx:width="0.6,0.47,0.23,0.33,0.6,0.53,0.66,0.49,0.55,0.23,0.55,0.55,0.83,0.23,0.45,0.5,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">ALI/ARDS in mice.</text>
   <text y="404.335" x="304.78,311.356,315.436,318.18,322.676,327.172,331.748,334.997" svgx:width="0.82,0.51,0.34,0.56,0.56,0.57,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Methods:</text>
   <text y="404.335" x="342.537,346.281,350.609,355.025,359.42499999999995,365.044,366.876,371.292,373.204,377.532,380.108,383.868,389.536,395.368,399.2,402.4,407.961,409.793,414.209,418.705,423.033,426.609,430.609,435.089,440.73,445.226,448.986,454.619,456.451,460.867,463.443,466.019,469.851,472.427,475.003,478.835,482.411,486.827,490.827,494.587,496.42699999999996,502.127,505.871,510.119,514.039,519.645,523.477,527.973,534.637,536.469" svgx:width="0.47,0.54,0.55,0.55,0.55,0.23,0.55,0.24,0.54,0.32,0.47,0.55,0.73,0.48,0.4,0.55,0.23,0.55,0.56,0.54,0.45,0.5,0.56,0.55,0.56,0.47,0.55,0.23,0.55,0.32,0.32,0.48,0.32,0.32,0.48,0.45,0.55,0.5,0.48,0.23,0.55,0.47,0.53,0.49,0.55,0.48,0.56,0.83,0.23,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Lung injury was induced by intratracheal LPS admi-</text>
   <text y="413.349" x="304.78,309.196,311.028,314.188,316.764,319.34,323.172,325.748,327.58,331.823,336.22299999999996,339.703,341.535,345.935,349.34,353.172,357.668,361.996,363.828,366.388,369.807,376.47,380.302,382.134,386.134,389.536,394.112,398.192,402.272,406.6,410.344,413.008,417.087,418.687,422.021,425.853,430.269,434.749,438.178,442.09,447.338,451.17,453.586,456.25,458.65,462.046,468.71,470.542,474.118,478.118,479.718,483.079,489.495,491.327,494.903,498.903,502.298,506.626,511.042,515.538,519.538,522.114,527.946,531.946,536.362" svgx:width="0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.55,0.23,0.55,0.55,0.48,0.56,0.54,0.23,0.32,0.55,0.83,0.48,0.23,0.5,0.55,0.57,0.51,0.51,0.54,0.47,0.33,0.51,0.2,0.55,0.48,0.55,0.56,0.55,0.49,0.66,0.48,0.3,0.33,0.3,0.55,0.83,0.23,0.45,0.5,0.2,0.55,0.8,0.23,0.45,0.5,0.55,0.54,0.55,0.56,0.5,0.32,0.73,0.5,0.55,0.32" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">nistration in adult male C57BL/6, and TNF-/- mice. Mice underwent</text>
   <text y="422.306" x="304.78,309.276,311.852,316.18,320.596,324.172,328.588,332.916,336.641,338.473,342.305,346.305,350.633,352.465,356.297,358.857,361.303,363.135,366.967,370.798,374.63,379.046,383.046,385.51,387.758,392.086,396.918,400.662,402.902,405.353,409.185,413.601,418.081,420.547,423.707,427.539,431.115,433.69,435.522,437.85,439.682,443.258,447.258,451.738,454.165,457.997,460.557,463.066,467.14599999999996,469.586,473.986,476.503,480.335,484.751,489.231,491.696,495.776,499.856,502.298,506.698,509.214,513.046,515.374,517.95,521.95,524.51,526.959,530.703,534.951" svgx:width="0.56,0.32,0.54,0.55,0.45,0.55,0.54,0.48,0.23,0.48,0.5,0.54,0.23,0.48,0.32,0.55,0.23,0.48,0.48,0.48,0.55,0.5,0.55,0.28,0.54,0.6,0.47,0.28,0.55,0.48,0.55,0.56,0.55,0.4,0.48,0.45,0.32,0.23,0.29,0.23,0.45,0.5,0.56,0.55,0.48,0.32,0.55,0.51,0.55,0.55,0.55,0.48,0.55,0.56,0.55,0.51,0.51,0.55,0.55,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.53,0.49" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">bronchoalveolar lavage (BAL) and sacrificed at 6 h and 24 h after LPS</text>
   <text y="431.321" x="304.78,308.612,313.108,319.772,321.604,326.02,327.852,330.916,333.492,336.068,339.9,342.476,344.308,348.636,353.052,354.65200000000004,357.335,362.495,364.327,367.487,370.063,374.39,376.222,380.466,384.882,386.714,390.289,394.121,395.96099999999996,398.664,401.824,405.4,409.728,412.304,416.304,418.959,423.287,425.60699999999997,428.314,433.146,436.89,438.72999999999996,441.41,447.242,451.073,454.27299999999997,456.887,460.719,463.879,467.039,471.039,474.199,477.359,481.359,485.839,488.522,490.354,494.75399999999996,497.423,499.254,503.582,507.998,512.398,515.11,517.686,519.518,522.678,525.838,530.166,534.166,537.326" svgx:width="0.48,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.2,0.55,0.64,0.23,0.4,0.32,0.54,0.23,0.54,0.55,0.23,0.45,0.48,0.23,0.55,0.4,0.45,0.54,0.32,0.5,0.55,0.54,0.29,0.55,0.6,0.47,0.23,0.55,0.73,0.48,0.4,0.55,0.48,0.4,0.4,0.5,0.4,0.4,0.5,0.56,0.55,0.23,0.55,0.55,0.23,0.54,0.55,0.55,0.55,0.32,0.23,0.4,0.4,0.54,0.5,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">administration. Histological score of ALI was assessed in lung tissues.</text>
   <text y="440.335" x="304.78,309.356,313.1,318.348,323.596,327.676,330.576,334.152,338.152,339.984,341.816,346.144,347.976,351.808,354.368,357.278,359.11,363.438,367.014,370.846,372.678,374.51,377.926,381.758,384.333,386.165,390.493,394.893,397.813,403.645,407.477,410.67699999999996,413.574,417.574,421.406,425.238,427.07,431.398,435.23,437.806,441.694,446.17400000000004,449.177,453.673,457.433,460.345,462.177,468.841,475.505,479.833,484.249,488.577,492.887,494.719,497.879,500.455,504.783,508.359,512.775,516.775,523.439,525.271,528.431,531.007,533.583,537.327" svgx:width="0.57,0.47,0.66,0.66,0.51,0.55,0.45,0.5,0.23,0.23,0.54,0.23,0.48,0.32,0.55,0.23,0.54,0.45,0.48,0.23,0.23,0.43,0.48,0.32,0.23,0.54,0.55,0.55,0.73,0.48,0.4,0.55,0.5,0.48,0.48,0.23,0.54,0.48,0.32,0.5,0.56,0.55,0.56,0.47,0.55,0.23,0.83,0.83,0.54,0.55,0.54,0.55,0.23,0.4,0.32,0.54,0.45,0.55,0.5,0.83,0.23,0.4,0.32,0.32,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">CLDN5 cellular localization was evaluated by immunohistochemistry,</text>
   <text y="449.349" x="304.78,310.612,315.028,316.86,318.692,322.692,325.02,326.852,329.428,332.628,334.998,338.998,342.662,347.158,349.734,353.734,356.894,360.054,361.886,366.123,370.52299999999997,372.926,374.758,378.758,382.59,386.59,388.422,391.622,393.959,399.791,403.791,406.367,410.367,412.724,416.556,420.556,423.132,424.964,427.292,429.124,433.124,437.60400000000004,439.937,444.433,448.193,450.595,457.339,461.339,464.499,467.075,471.075,473.651,478.051,480.415,484.911,486.743,491.071,493.647,496.223,498.055,502.471,506.778" svgx:width="0.73,0.55,0.23,0.23,0.5,0.55,0.23,0.32,0.4,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.73,0.5,0.32,0.5,0.55,0.48,0.5,0.32,0.23,0.29,0.23,0.5,0.56,0.55,0.56,0.47,0.55,0.84,0.5,0.4,0.32,0.5,0.32,0.55,0.55,0.56,0.23,0.54,0.32,0.32,0.23,0.55,0.55,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">while its expression levels were verified by Western blotting.</text>
   <text y="458.307" x="304.78,309.276,313.356,316.684,321.18,323.18,325.924,329.252" svgx:width="0.56,0.51,0.42,0.56,0.25,0.34,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Results:</text>
   <text y="458.307" x="333.637,335.469,339.86899999999997,342.481,349.144,350.976,354.552,358.552,361.132,362.964,367.292,371.708,376.108,378.707,381.283,383.115,386.275,389.435,393.763,397.763,399.363,401.895,404.223,408.551,410.383,412.215,416.543,422.375,424.207,428.623,433.02299999999997,435.571,439.315,443.563,447.483,450.084,453.916,458.412,465.076,466.908,471.324,473.156,476.22,478.796,481.372,485.204,487.779,489.611,493.939,498.355,499.95500000000004,502.525,507.101,510.845,516.093,521.341,525.421,527.98,529.812,536.476" svgx:width="0.23,0.55,0.55,0.83,0.23,0.45,0.5,0.55,0.23,0.54,0.55,0.55,0.55,0.32,0.23,0.4,0.4,0.54,0.5,0.2,0.55,0.29,0.54,0.23,0.23,0.54,0.73,0.23,0.55,0.55,0.55,0.47,0.53,0.49,0.55,0.48,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.2,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.23,0.83,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">In mice lung tissue, following LPS administration, CLDN5 im-</text>
   <text y="467.321" x="304.78,311.444,315.772,320.188,324.516,327.092,331.092,334.828,338.404,340.98,342.812,346.644,348.476,351.052,354.812,359.149,364.981,368.813,372.013,376.327,380.823,382.655,385.815,388.391,390.967,392.799,397.295,401.623,404.199,408.199,412.67900000000003,417.033,420.865,422.697,427.025,431.441,435.84099999999995,440.164,442.74,447.156,451.156,455.528,459.36,461.192,465.024,469.024,473.352,475.184,479.015,481.575,485.915,489.915,494.411,496.243,498.819,503.235,507.235,509.067,510.899,515.113,521.753,526.168,530.0,534.416" svgx:width="0.83,0.54,0.55,0.54,0.32,0.5,0.48,0.45,0.32,0.23,0.48,0.23,0.32,0.47,0.55,0.73,0.48,0.4,0.55,0.56,0.23,0.4,0.32,0.32,0.23,0.56,0.54,0.32,0.5,0.56,0.55,0.48,0.23,0.54,0.55,0.55,0.55,0.32,0.55,0.5,0.55,0.48,0.23,0.48,0.5,0.54,0.23,0.48,0.32,0.55,0.5,0.56,0.23,0.32,0.55,0.5,0.23,0.23,0.54,0.83,0.55,0.48,0.55,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">munoreactivity was distributed along the alveolar epithelium and</text>
   <text y="476.335" x="304.78,308.612,312.444,315.604,319.18,323.508,325.34,329.172,331.732,334.09,338.09,342.506,347.002,351.33,353.906,358.322,362.322,364.154,365.986,370.314,376.978,378.57800000000003,380.918,385.494,389.238,394.486,399.734,403.81399999999996,406.204,410.7,413.276,417.603,420.179,424.179,426.011,430.411,432.793,436.793,440.457,444.953,447.529,451.529,454.689,457.849,459.681,463.917,468.31699999999995,470.777,472.609,476.609,480.441,484.441,486.273,489.473,491.81,497.642,501.474,504.674,507.061,508.893,513.309,516.885,519.461,523.46,527.292,530.361,534.361" svgx:width="0.48,0.48,0.4,0.45,0.54,0.23,0.48,0.32,0.55,0.5,0.55,0.56,0.54,0.32,0.55,0.5,0.23,0.23,0.54,0.83,0.2,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.56,0.32,0.54,0.32,0.5,0.23,0.55,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.55,0.73,0.48,0.4,0.55,0.23,0.55,0.45,0.32,0.5,0.48,0.4,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">vascular endothelium. CLDN5 protein expression levels was increased</text>
   <text y="485.349" x="304.78,309.146,312.906,315.438,319.518,322.071,324.282,328.61,330.235,334.71500000000003,337.265,341.097,342.764,346.959,351.375,355.775,358.241,364.073,365.668,368.244,372.644,375.079,379.911,383.47,385.31,387.835,391.411,395.659,399.344,401.92,405.58,409.156,411.532,415.532,417.939,419.771,422.758,425.334,426.953,430.529,433.729,436.137,438.385,442.033,446.228,450.644,457.113,461.113,465.333,467.909,471.683,476.163,478.712,480.544,484.94399999999996,487.387,491.715,496.344,500.088,503.928,506.378,509.837,513.837,515.506,517.207,521.535,523.217,526.901,529.477,531.153,533.729,537.276" svgx:width="0.56,0.47,0.55,0.51,0.55,0.29,0.54,0.23,0.56,0.55,0.48,0.23,0.54,0.55,0.55,0.55,0.73,0.23,0.32,0.55,0.55,0.6,0.47,0.23,0.55,0.45,0.55,0.48,0.32,0.48,0.45,0.32,0.5,0.32,0.23,0.4,0.32,0.23,0.45,0.4,0.55,0.28,0.48,0.54,0.55,0.83,0.5,0.55,0.32,0.5,0.56,0.55,0.23,0.55,0.55,0.54,0.6,0.47,0.48,0.55,0.45,0.5,0.23,0.23,0.54,0.23,0.48,0.32,0.23,0.32,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">by 3 fold along with ALI characteristics (augmented in BALF cellularity,</text>
   <text y="494.307" x="304.78,309.146,311.722,315.892,318.468,322.242,324.074,328.474,330.632,334.09,338.418,342.651,345.227,349.0,353.416,355.976,358.128,361.96,366.179,370.659,372.868,377.574,381.318,383.15799999999996,385.284,388.444,391.804,396.132,398.55,402.55,404.616,406.216,408.415,410.116,414.51599999999996,416.748,420.547,425.795,429.447,431.863,434.323,436.72299999999996,438.915,445.579,447.249,450.707,454.707,456.307,458.417,462.993,466.525,471.772,476.843,480.923,483.079,487.079,490.562,495.058,497.422,501.422,504.395,507.555,509.214,513.542,517.942,520.043,521.875,525.075,527.186,530.346,532.742,536.427" svgx:width="0.56,0.32,0.54,0.32,0.5,0.23,0.55,0.55,0.45,0.54,0.55,0.32,0.5,0.55,0.32,0.55,0.48,0.55,0.56,0.55,0.6,0.47,0.23,0.55,0.4,0.45,0.54,0.32,0.5,0.28,0.2,0.55,0.23,0.55,0.55,0.49,0.66,0.48,0.3,0.33,0.3,0.55,0.83,0.23,0.45,0.5,0.2,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.23,0.4,0.55,0.4,0.32,0.48,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">protein content and ALI score). In TNF-/- mice, CLDN5 expression is sta-</text>
   <text y="503.321" x="304.78,307.356,308.975,312.135,314.531,316.363,319.747,323.579,325.246,326.947,330.707,333.807,336.383,340.157,344.652,348.774,352.35,356.201,360.68100000000004,363.741,367.573,370.77299999999997,373.719,377.719,381.373,383.949,385.568,389.328,392.428,396.113,399.313,402.405,406.48499999999996,409.548,413.948,417.032,420.863,422.984,425.56,429.391,431.951,435.06,438.688,442.936,446.856,449.857,453.542,458.037,464.54,466.241,470.656,472.307,475.467,477.863,480.439,484.099,486.536,488.368,492.546,496.94599999999997,500.029,505.861,507.456,510.032,514.432,517.434,521.01,525.145,529.561,532.572,536.427" svgx:width="0.32,0.23,0.4,0.32,0.23,0.45,0.48,0.23,0.23,0.47,0.55,0.32,0.5,0.56,0.54,0.45,0.5,0.56,0.55,0.48,0.4,0.55,0.5,0.48,0.32,0.23,0.47,0.55,0.48,0.4,0.55,0.51,0.55,0.55,0.55,0.48,0.29,0.32,0.5,0.32,0.55,0.47,0.53,0.49,0.55,0.48,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.55,0.73,0.23,0.32,0.55,0.55,0.45,0.54,0.55,0.4,0.5,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">tistically reduced as early as 6 h after LPS administration with conse-</text>
   <text y="512.336" x="304.78,309.146,313.474,317.31,321.726,324.113,325.814,329.574,334.657,336.489,340.724,344.182,346.758,350.588,354.42,357.392,361.391,365.87100000000004,370.884,372.585,376.98499999999996,382.11,386.438,391.067,394.811,398.65099999999995,403.653,408.148,410.512,414.84,417.259,421.259,422.871,427.27099999999996,432.396,435.854,440.182,444.415,446.991,450.822,455.237,457.625,459.225,464.257,466.089,470.489,475.539,479.371,483.646,488.142,489.769,492.345,494.021,498.216,502.616,507.741,509.573,513.807,517.265,519.841,523.672,527.504,530.475,534.475" svgx:width="0.56,0.54,0.5,0.55,0.32,0.23,0.47,0.55,0.23,0.55,0.45,0.32,0.5,0.48,0.4,0.5,0.56,0.55,0.23,0.55,0.55,0.54,0.6,0.47,0.48,0.55,0.56,0.32,0.54,0.32,0.5,0.23,0.55,0.55,0.45,0.54,0.55,0.32,0.5,0.55,0.32,0.2,0.55,0.23,0.55,0.55,0.48,0.56,0.56,0.23,0.32,0.23,0.54,0.55,0.55,0.23,0.55,0.45,0.32,0.5,0.48,0.4,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">quently increased in BALF protein content. In addition increased</text>
   <text y="521.35" x="304.78,309.356,312.887,318.135,323.206,327.286,329.498,333.498,336.981,341.477,343.841,347.841,350.815,353.975,355.634,359.962,364.36199999999997,366.519,372.351,375.986,379.186,381.429,385.757,390.046,393.206,397.02,399.596,403.256,407.111,411.591,413.914,418.109,422.605,426.727,431.12699999999995,433.416,437.385,441.465,443.734,448.13399999999996,450.424,454.168,458.248,462.168,464.427,468.112,472.608,479.11,480.811,485.227,486.877,490.037,492.433,495.009,498.669,501.106,502.938,507.116,511.532,513.132,515.28,519.078,524.326,528.166,530.304,534.8,536.427" svgx:width="0.57,0.47,0.66,0.66,0.51,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.73,0.48,0.4,0.55,0.54,0.56,0.4,0.5,0.32,0.48,0.5,0.56,0.55,0.54,0.56,0.54,0.55,0.55,0.51,0.51,0.55,0.55,0.55,0.47,0.53,0.49,0.55,0.48,0.56,0.83,0.23,0.55,0.23,0.4,0.32,0.32,0.48,0.32,0.23,0.54,0.55,0.2,0.55,0.49,0.66,0.48,0.55,0.56,0.23,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">CLDN5 expression was observed upon 24 h LPS administration. TNF bi-</text>
   <text y="530.307" x="304.78,309.146,313.562,317.196,320.356,322.015,325.615,328.194,332.026,335.394,337.97,339.646,343.841,348.241,350.871,355.199,359.599,362.096,366.672,370.26,375.362,380.61,384.69,387.211,391.211,394.694,399.06,401.636,405.466,408.626,411.589,413.421,417.542,421.94199999999995,424.571,430.403,434.039,437.239,439.766,444.262,448.099,452.465,456.465,460.685,465.181,468.963,473.379,475.939,478.488,482.816,487.21599999999995,489.713,493.625,497.707,501.902,505.87,508.534,512.614,515.168,519.023,522.687,527.017,529.593,533.366,536.526" svgx:width="0.56,0.55,0.48,0.4,0.23,0.45,0.55,0.48,0.45,0.32,0.23,0.54,0.55,0.55,0.54,0.55,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.55,0.73,0.48,0.4,0.55,0.56,0.5,0.56,0.5,0.55,0.56,0.5,0.55,0.32,0.55,0.54,0.55,0.55,0.49,0.53,0.54,0.51,0.33,0.51,0.55,0.5,0.46,0.56,0.32,0.5,0.4,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">phasic action on CLDN5 expression was dependent on ERK1/2 expres-</text>
   <text y="539.322" x="304.78,307.94,309.599,313.794,318.19399999999996,320.258,322.09,325.927,329.612,333.612,335.281,338.441" svgx:width="0.4,0.23,0.54,0.55,0.55,0.23,0.5,0.48,0.5,0.23,0.4,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">sion levels.</text>
   <text y="548.336" x="304.78,309.444,313.94,318.436,322.012,324.012,328.508,331.836,333.836,338.229,342.725,346.053" svgx:width="0.58,0.56,0.56,0.45,0.25,0.56,0.42,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Conclusions:</text>
   <text y="548.336" x="350.475,352.307,356.707,359.262,363.006,367.254,371.17400000000004,373.719,375.551,379.966,384.462,388.79,392.366,396.366,400.846,403.425,408.257,412.001,413.833,416.497,421.329,425.577,430.825,434.745,437.215,439.047,443.447,446.058,452.722,454.554,458.13,462.13,463.73,466.241,470.817,474.561,479.809,485.057,489.137,491.64,497.472,501.304,504.50399999999996,507.004,508.836,513.252,516.828,519.404,523.404,527.236,530.396,534.396" svgx:width="0.23,0.55,0.55,0.47,0.53,0.49,0.55,0.23,0.55,0.56,0.54,0.45,0.5,0.56,0.55,0.6,0.47,0.23,0.33,0.6,0.53,0.66,0.49,0.55,0.23,0.55,0.55,0.83,0.23,0.45,0.5,0.2,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.73,0.48,0.4,0.55,0.23,0.55,0.45,0.32,0.5,0.48,0.4,0.5,0.56" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">In LPS induced ALI/ARDS in mice, CLDN5 was increased</text>
   <text y="557.35" x="304.78,308.612,311.772,314.932,319.26,322.836,324.668,328.5,331.076,334.997,339.47700000000003,344.125,349.957,351.789,354.365,358.765,363.401,368.233,371.977,373.81699999999995,378.368,381.528,385.528,389.36,393.36,395.936,397.768,400.344,404.088,405.68800000000005,410.286,416.702,421.03,423.606,427.606,431.934,435.766,439.653,442.229,443.829,448.44,452.352,457.6,461.44,466.072,468.648,472.648,477.064,481.391,483.223,487.055,489.631,493.631,496.83099999999996,501.334,505.91,509.654,514.902,520.15,524.23,528.831,532.831,536.495" svgx:width="0.48,0.4,0.4,0.54,0.45,0.23,0.48,0.32,0.5,0.56,0.55,0.73,0.23,0.32,0.55,0.55,0.6,0.47,0.23,0.55,0.4,0.5,0.48,0.5,0.32,0.23,0.32,0.47,0.2,0.55,0.8,0.54,0.32,0.5,0.54,0.48,0.5,0.32,0.2,0.55,0.49,0.66,0.48,0.55,0.32,0.5,0.55,0.54,0.23,0.48,0.32,0.5,0.4,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.5,0.46,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">associated with ALI severity. Moreover, TNF regulates CLDN5 ex-</text>
   <text y="566.308" x="304.78,309.146,311.722,315.552,318.712,321.675,323.507,327.628,332.044,333.644,336.415,340.247,344.465,348.945,351.779,355.577,358.489,361.68899999999996,364.421,368.917,372.755,375.192,381.856,385.68,389.512,393.787,395.619,397.245,399.077,401.497,405.257,408.073,412.569,416.407,420.772,424.772,428.993,433.359,437.359,441.579,444.139,447.022,448.854,453.25399999999996,456.036,460.532,464.143,466.719,469.279,472.08,476.408,480.808,483.588,487.387,491.635,495.777,499.746,502.297,506.377,509.27,513.636,517.468,519.872,524.288,529.907,533.739,537.277" svgx:width="0.56,0.32,0.5,0.4,0.4,0.23,0.54,0.55,0.2,0.55,0.48,0.55,0.56,0.55,0.49,0.36,0.4,0.55,0.56,0.5,0.32,0.83,0.5,0.48,0.56,0.23,0.23,0.23,0.32,0.47,0.55,0.56,0.5,0.56,0.5,0.55,0.56,0.5,0.55,0.32,0.55,0.23,0.55,0.55,0.56,0.48,0.32,0.32,0.55,0.54,0.55,0.55,0.49,0.53,0.54,0.51,0.33,0.51,0.55,0.56,0.48,0.32,0.55,0.73,0.48,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">pression, and TJs permeability dependent in part on ERK1/2 pathway.</text>
   <text y="575.322" x="304.78,310.166,314.361,316.921,319.01,321.221,323.053,327.287,331.653,333.485,337.719,342.135,345.335,347.244,351.099,357.763,361.587,364.163,368.39,372.39,374.399,376.837,381.253,385.253,387.212,389.649,393.977,395.659,399.659,401.668,405.864,408.18399999999997,410.229,414.805,416.465,420.297,424.402,428.898,430.525,434.941,438.14099999999996,440.05,443.882,448.1,452.58000000000004,454.62,458.475,461.635,465.958,469.958,473.328,475.16,478.827,480.528,482.36,486.12,488.068,492.644,496.175,501.423,506.437,510.517,512.56,515.136,519.456,521.404,525.259,527.091,531.268,534.727,536.559" svgx:width="0.69,0.54,0.32,0.55,0.29,0.23,0.55,0.56,0.23,0.55,0.55,0.4,0.55,0.5,0.83,0.5,0.32,0.55,0.5,0.55,0.32,0.55,0.5,0.55,0.32,0.54,0.23,0.5,0.55,0.54,0.29,0.55,0.57,0.23,0.48,0.54,0.56,0.23,0.55,0.4,0.55,0.48,0.55,0.56,0.55,0.5,0.4,0.56,0.5,0.45,0.23,0.48,0.23,0.23,0.47,0.55,0.57,0.47,0.66,0.66,0.51,0.55,0.32,0.54,0.55,0.5,0.23,0.54,0.45,0.23,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Our findings emerge the role of Claudins and especially CLDN5 to eluci-</text>
   <text y="584.336" x="304.78,309.146,312.978,315.382,319.382,321.448,324.024,328.251,332.251,334.317,338.683,342.515,344.919,349.335,353.423,357.919,362.153,365.781,368.941,370.6,374.928,376.553,380.881,385.114,388.87399999999997,390.896,395.224,397.544,399.57,402.008,406.424,408.074,411.274,413.29,415.618,419.753,422.329,428.969,430.979,435.306,437.626,439.596,441.428,445.662,447.574,451.672,454.248,457.852" svgx:width="0.56,0.48,0.32,0.5,0.55,0.32,0.55,0.5,0.55,0.56,0.48,0.32,0.55,0.54,0.56,0.55,0.47,0.4,0.23,0.54,0.23,0.54,0.55,0.47,0.55,0.54,0.29,0.55,0.32,0.55,0.23,0.4,0.55,0.29,0.54,0.32,0.83,0.55,0.54,0.29,0.55,0.23,0.55,0.24,0.54,0.32,0.47,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">date the pathophysiology of this form of injury.</text>
   <text y="605.313" x="304.78,309.356,313.772,318.188" svgx:width="0.57,0.55,0.55,0.55" style="fill:rgb(235,103,59);font-family:AdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;">P269</text>
   <text y="614.327" x="304.78,309.444,313.524,315.524,317.524,319.861,323.437,327.933,332.429,336.925,339.669,343.029,345.372,347.372,351.85200000000003,354.273,358.353,362.849,367.425,371.921,376.585,379.417,383.81,388.306,391.882,396.378,398.378,402.378,404.378,406.714,410.714,414.042,418.706,420.706,423.538,427.538,430.282,434.36199999999997,436.705,439.449,443.92900000000003,446.342,450.342,453.67,456.998,461.078,464.406,467.766,470.097,474.097,476.096,478.928,484.84,488.84" svgx:width="0.58,0.51,0.25,0.25,0.55,0.45,0.56,0.56,0.56,0.34,0.42,0.55,0.25,0.56,0.55,0.51,0.56,0.57,0.56,0.58,0.35,0.56,0.56,0.45,0.56,0.25,0.5,0.25,0.55,0.5,0.42,0.58,0.25,0.35,0.5,0.34,0.51,0.55,0.34,0.56,0.55,0.5,0.42,0.42,0.51,0.42,0.42,0.55,0.5,0.25,0.35,0.74,0.5,0.5" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Cell counts in endobronchial aspirate to assess airway</text>
   <text y="623.341" x="304.78,306.78,311.276,313.772,315.772,319.772,326.516,333.26,337.152,339.896,341.896,346.392,350.872,353.252,355.252,359.732,362.153,367.233,371.729,377.145,381.22499999999997,383.583,388.247,392.247,394.991,396.991,401.071,405.567,408.311,411.639,413.479,415.785,419.785,422.191,426.855,428.855,430.855,435.351,438.071,440.446,443.774,446.518,451.014,455.59" svgx:width="0.25,0.56,0.31,0.25,0.5,0.84,0.84,0.5,0.34,0.25,0.56,0.56,0.55,0.25,0.56,0.55,0.63,0.56,0.68,0.51,0.55,0.58,0.5,0.34,0.25,0.51,0.56,0.34,0.42,0.23,0.55,0.5,0.55,0.58,0.25,0.25,0.56,0.34,0.55,0.42,0.34,0.56,0.57,0.5" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">inflammation in ARDS patients: a pilot study</text>
   <text y="632.356" x="304.78,308.444,309.80400000000003,312.15,315.814,320.142,323.718,328.046,331.622,333.95" svgx:width="0.46,0.17,0.55,0.46,0.54,0.45,0.54,0.45,0.29,0.53" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">S. Spadaro</text>
   <text y="628.781" x="338.173" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="632.353" x="341.008,342.368,344.749,346.413,347.773,350.135,354.047,358.295,361.455,365.703,369.535,373.111,377.359,379.023,382.351,386.598,390.103" svgx:width="0.17,0.55,0.21,0.17,0.55,0.49,0.53,0.4,0.53,0.48,0.45,0.53,0.21,0.42,0.53,0.45,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, I. Kozhevnikova</text>
   <text y="628.781" x="393.676" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="632.353" x="396.567,397.927,400.252,403.915,405.27500000000003,407.679,412.839,416.415,418.079,419.742,423.34200000000004,425.65,430.146,434.394,436.722,439.138" svgx:width="0.17,0.55,0.46,0.17,0.55,0.64,0.45,0.21,0.21,0.45,0.55,0.56,0.53,0.29,0.3,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, F. Dalla Corte</text>
   <text y="628.781" x="442.942" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="632.353" x="445.833,447.19300000000004,449.574,453.238,454.598,456.945,461.857,464.185,467.761,470.673,473.584" svgx:width="0.17,0.55,0.46,0.17,0.55,0.61,0.29,0.45,0.36,0.36,0.53" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, S. Grasso</text>
   <text y="628.781" x="477.808" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="632.353" x="480.642,482.002,484.384,488.384,489.744,492.094,496.59,500.166,503.078,507.326,508.99,512.566,514.894" svgx:width="0.17,0.55,0.5,0.17,0.55,0.56,0.45,0.36,0.53,0.21,0.45,0.29,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, P. Casolari</text>
   <text y="628.781" x="516.529" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="632.353" x="519.42" svgx:width="0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">,</text>
   <text y="641.31" x="304.782,309.694,311.05400000000003,313.4,317.896,321.472,323.8,327.376,333.871,338.119,340.447" svgx:width="0.61,0.17,0.55,0.56,0.45,0.29,0.45,0.81,0.53,0.29,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">G. Caramori</text>
   <text y="637.795" x="342.085" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="641.31" x="344.92,346.28000000000003,348.661,353.157,354.517,356.882,360.882,365.13,366.794,369.21" svgx:width="0.17,0.55,0.56,0.17,0.55,0.5,0.53,0.21,0.3,0.45" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">, C. Volta</text>
   <text y="637.795" x="372.756" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="646.753" x="304.781" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">1</text>
   <text y="650.324" x="307.616,312.616,316.864,318.528,322.104,325.935,328.263,331.175,332.839,335.255,338.775,341.121,345.369,347.449,349.795,353.459,357.291,359.619,361.947,365.523,367.851,371.427,372.78700000000003,375.137,378.801,382.633,384.961,387.289,390.865,393.193,396.769,398.129,400.479,402.143,404.559,408.135,409.799,413.295" svgx:width="0.63,0.53,0.21,0.45,0.48,0.29,0.36,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.46,0.48,0.29,0.29,0.45,0.29,0.45,0.17,0.55,0.46,0.48,0.29,0.29,0.45,0.29,0.45,0.17,0.55,0.21,0.3,0.45,0.21,0.44,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">University of Ferrara, Ferrara, Italy;</text>
   <text y="646.753" x="416.976" svgx:width="0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:5.33px;stroke:none;">2</text>
   <text y="650.324" x="419.868,424.868,429.116,430.779,434.355,438.187,440.515,443.427,445.091,447.42,450.94,453.316,457.564,459.644,462.047,466.047,469.623,471.951,473.615,474.975,477.297,481.297,484.873,487.201,488.865,490.225,492.604,494.268,496.684,500.26,501.924" svgx:width="0.63,0.53,0.21,0.45,0.48,0.29,0.36,0.21,0.3,0.44,0.55,0.53,0.26,0.55,0.5,0.45,0.29,0.21,0.17,0.55,0.5,0.45,0.29,0.21,0.17,0.55,0.21,0.3,0.45,0.21,0.44" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">University of Bari, Bari, Italy</text>
   <text y="659.339" x="304.781,308.816,310.952,312.449,314.661,316.158,319.243,323.043,324.64300000000003,326.778,330.813,334.613,336.812" svgx:width="0.53,0.28,0.2,0.29,0.2,0.41,0.5,0.2,0.55,0.53,0.5,0.28,0.42" style="fill:rgb(19,20,19);font-family:AdvTT1b53b5fb.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="659.339" x="342.255,345.895,349.536,353.176,356.882" svgx:width="0.48,0.48,0.48,0.48,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">2016,</text>
   <text y="659.339" x="360.397,364.433,368.468,370.68,374.627,378.898,383.328,387.759,389.759,391.975,396.01,398.222" svgx:width="0.53,0.53,0.29,0.51,0.56,0.58,0.58,0.25,0.55,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">20(Suppl 2):</text>
   <text y="659.339" x="399.969,403.769,407.409,411.049" svgx:width="0.5,0.48,0.48,0.48" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">P269</text>
   <text y="677.31" x="304.781,306.861,311.357,314.101,316.933,321.429,326.005,330.501,334.077,336.821,338.74,343.236,347.732,351.06" svgx:width="0.26,0.56,0.34,0.35,0.56,0.57,0.56,0.45,0.34,0.25,0.56,0.56,0.42,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Introductions:</text>
   <text y="677.31" x="357.448,362.28,366.776,371.104,372.936,375.496,380.126,382.702,386.702,389.862,394.357,396.189,398.765,402.597,405.173,409.501,411.987,415.747,420.32,424.816,426.648,429.808,432.384,434.96,438.96,442.12,445.32,449.858,453.017,456.761,461.177,465.673,468.249,472.577,479.241,483.241,487.785,490.033,494.865,499.113,504.361,508.273,510.51300000000003,515.054,516.886,520.086,524.636,528.212,532.628,536.46" svgx:width="0.6,0.56,0.54,0.23,0.32,0.55,0.32,0.5,0.4,0.56,0.23,0.32,0.48,0.32,0.54,0.32,0.47,0.55,0.56,0.23,0.4,0.32,0.32,0.5,0.4,0.4,0.55,0.4,0.47,0.55,0.56,0.32,0.54,0.83,0.5,0.55,0.28,0.6,0.53,0.66,0.49,0.28,0.55,0.23,0.4,0.55,0.45,0.55,0.48,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">Adult respiratory distress syndrome (ARDS) is cha-</text>
   <text y="686.325" x="304.781,307.357,311.189,314.765,317.341,321.341,323.917,325.749,329.165,333.071,337.55100000000004,340.554,345.05,348.81,351.723,355.563,358.469,362.965,365.541,369.541,373.373,377.117,381.613,385.941,391.773,396.173,399.061,403.389,405.709,408.699,412.275,416.107,420.603,422.435,424.267,426.099,429.931,432.506,436.26599999999996,439.143,440.975,445.391,447.967,451.967,456.383,458.959,460.791,463.367,467.111,468.711,471.572,473.404,477.403,481.235,485.731,487.563,491.979,496.37899999999996,499.294,501.87,506.19,509.159,511.735,516.151,520.151,523.048,524.88,528.88,532.712,536.456" svgx:width="0.32,0.48,0.45,0.32,0.5,0.32,0.23,0.43,0.5,0.56,0.55,0.56,0.47,0.55,0.48,0.55,0.56,0.32,0.5,0.48,0.47,0.56,0.54,0.73,0.55,0.55,0.54,0.29,0.55,0.45,0.48,0.56,0.23,0.23,0.23,0.48,0.32,0.47,0.55,0.23,0.55,0.32,0.5,0.55,0.32,0.23,0.32,0.47,0.2,0.55,0.23,0.5,0.48,0.56,0.23,0.55,0.55,0.55,0.32,0.54,0.55,0.32,0.55,0.5,0.55,0.23,0.5,0.48,0.47,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">racterized by a breakdown of capillary integrity, leading to the leak-</text>
   <text y="695.339" x="304.781,308.613,313.029,317.029,320.031,324.359,326.679,329.669,334.165,336.741,341.069,343.644,347.644,349.476,353.892,356.308,358.884,360.716,364.292,368.69199999999995,371.678,374.006,375.838,380.166,381.998,386.478,389.48,393.312,397.728,402.208,405.24,407.816,412.232,416.232,419.187,423.019,426.595,430.171,434.498,441.162,445.49,447.322,451.154,453.656,455.488,459.816,464.21599999999995,467.262,471.59,473.90999999999997,476.9,478.731,483.147,485.475,487.307,491.139,497.803,504.467,508.299,510.875,515.203,517.779,521.539,524.465,528.041,532.041,533.873,535.705" svgx:width="0.48,0.55,0.5,0.55,0.54,0.29,0.55,0.56,0.32,0.54,0.32,0.5,0.23,0.55,0.3,0.32,0.23,0.45,0.55,0.55,0.29,0.23,0.54,0.23,0.56,0.55,0.48,0.55,0.56,0.55,0.32,0.55,0.5,0.55,0.48,0.45,0.45,0.54,0.83,0.54,0.23,0.48,0.32,0.23,0.54,0.55,0.55,0.54,0.29,0.55,0.23,0.55,0.29,0.23,0.48,0.83,0.83,0.48,0.32,0.54,0.32,0.47,0.55,0.45,0.5,0.23,0.23,0.4" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">age of protein-rich fluid and the accumulation of inflammatory cells</text>
   <text y="704.353" x="304.781,310.613,312.445,315.021,319.437,321.269,325.669,328.875,331.451,335.867,339.867,343.049,346.88,348.712,351.288,354.448,358.944,362.776,366.352,370.352,373.512,375.112,378.311,382.639,385.215,389.543,393.959,397.535,401.951,406.279,410.003,411.835,415.667,419.667,423.995,425.827,429.659,432.219,435.458,437.29,441.122,444.953,448.785,453.201,457.201,460.346,462.594,466.922,471.754,475.498,477.738,480.983,482.815,486.015,489.203,491.779,496.195,500.195,503.377,506.953,511.281,517.945,524.609,528.936,533.352,535.184" svgx:width="0.73,0.23,0.32,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.48,0.23,0.32,0.4,0.56,0.48,0.45,0.5,0.4,0.2,0.55,0.54,0.32,0.54,0.55,0.45,0.55,0.54,0.48,0.23,0.48,0.5,0.54,0.23,0.48,0.32,0.55,0.23,0.48,0.48,0.48,0.55,0.5,0.55,0.28,0.54,0.6,0.47,0.28,0.55,0.23,0.4,0.55,0.32,0.55,0.5,0.55,0.45,0.54,0.83,0.83,0.54,0.55,0.23,0.47" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">within the airspaces. Bronchoalveolar lavage (BAL) is the commonly</text>
   <text y="713.311" x="304.781,309.109,312.269,316.269,320.749,323.036,329.7,333.7,336.276,340.692,345.02,349.5,351.78,354.356,358.676,361.02,365.348,369.844,372.42,376.252,378.084,382.484,384.774,386.606,390.934,396.766,400.766,403.326,405.637,408.213,412.213,415.373,419.869,421.701,424.277,428.109,430.685,435.013,437.498,441.258,443.565,446.141,448.717,452.549,456.125,458.701,461.901,464.201,467.361,471.193,477.857,482.353,484.185,488.185,491.385,493.625,497.457,501.873,506.353,508.649,511.225,515.5450000000001,517.889,522.385,526.385,528.713,530.545,534.961" svgx:width="0.54,0.4,0.5,0.56,0.55,0.83,0.5,0.32,0.55,0.54,0.56,0.55,0.32,0.54,0.55,0.54,0.56,0.32,0.48,0.23,0.55,0.55,0.23,0.54,0.73,0.5,0.32,0.55,0.32,0.5,0.4,0.56,0.23,0.32,0.48,0.32,0.54,0.32,0.47,0.55,0.32,0.32,0.48,0.45,0.32,0.4,0.55,0.4,0.48,0.83,0.56,0.23,0.5,0.4,0.55,0.48,0.55,0.56,0.55,0.32,0.54,0.55,0.56,0.5,0.29,0.23,0.55,0.5" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">used method to obtain lower respiratory tracts samples and to define</text>
   <text y="722.325" x="304.781,307.357,311.773,315.773,319.748,322.324,326.652,328.484,332.484,336.529,340.857,343.177,347.188,350.764,354.764,356.596,358.427,361.627,365.613,367.445,371.84499999999997,375.874,378.45,382.866,386.866,390.898,392.73,397.146,399.474,401.306,405.138,411.802,418.466,422.193,424.769,429.097,431.673,435.433,439.428,442.004,446.004,449.164,453.66,457.988,462.404,465.564,469.564,473.557,475.389,479.789,483.819,488.651,492.899,498.146,502.058,503.658,507.63,512.789,517.117,522.949,526.949,530.781,534.781,537.357" svgx:width="0.32,0.55,0.5,0.55,0.32,0.54,0.23,0.5,0.55,0.54,0.29,0.55,0.45,0.5,0.23,0.23,0.4,0.55,0.23,0.55,0.55,0.32,0.55,0.5,0.55,0.23,0.55,0.29,0.23,0.48,0.83,0.83,0.48,0.32,0.54,0.32,0.47,0.55,0.32,0.5,0.4,0.56,0.54,0.55,0.4,0.5,0.55,0.23,0.55,0.55,0.6,0.53,0.66,0.49,0.2,0.55,0.64,0.54,0.73,0.5,0.48,0.5,0.32,0.2" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">the role of cells in the inflammatory response in ARDS. However,</text>
   <text y="731.339" x="304.781,307.357,311.773,315.773,318.349,322.349,326.268,328.1,331.3,335.225,337.801,342.217,346.217,350.192,354.608,358.608,362.608,367.088,371.055,373.631,377.95099999999996,381.884,385.716,388.876,392.036,396.036,399.196,402.396,406.319,408.895,413.311,417.311,421.286,423.614,427.614,431.446,434.606,436.438,440.934,442.766,444.598,446.43,449.006,452.76599999999996,456.662,460.99,463.31,467.264,471.592,474.752,476.584,481.0,485.4,489.374,491.95,495.95,497.782,501.614,504.19,506.022,509.854,513.752,515.584,519.3439999999999,523.333,527.748,532.076,536.492" svgx:width="0.32,0.55,0.5,0.32,0.5,0.55,0.23,0.4,0.55,0.32,0.55,0.5,0.55,0.55,0.5,0.5,0.56,0.55,0.32,0.54,0.55,0.48,0.4,0.4,0.5,0.4,0.4,0.55,0.32,0.55,0.5,0.55,0.29,0.5,0.48,0.4,0.23,0.56,0.23,0.23,0.23,0.32,0.47,0.55,0.54,0.29,0.55,0.54,0.4,0.23,0.55,0.55,0.55,0.32,0.5,0.23,0.48,0.32,0.23,0.48,0.5,0.23,0.47,0.55,0.55,0.54,0.55,0.3" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">there is the need to assess the feasibility of using relatively non-</text>
  </g>
  <path style="fill:rgb(19,20,19);stroke:none;stroke-width:1.0;" d="M56.520 299.060 L290.610 299.060 L290.610 299.170 L56.520 299.170 "/>
  <g begin="text">
   <text y="286.016" x="56.523,60.683,64.683,69.347,71.347,75.42699999999999,77.726,81.974,86.214,88.61,90.938,96.018,100.682,104.01,106.754,109.586,113.586,117.162,119.882,122.286,126.702,130.95,135.198,139.446,141.774" svgx:width="0.52,0.5,0.58,0.25,0.51,0.55,0.53,0.53,0.55,0.29,0.63,0.58,0.42,0.34,0.35,0.5,0.45,0.34,0.55,0.55,0.53,0.53,0.53,0.29,0.23" style="fill:rgb(19,20,19);font-family:AdvTT99c4c969;font-size:8.0px;stroke:none;">Table 36 (Abstract P266).</text>
   <text y="286.016" x="145.927,150.423,154.671,158.247,160.575,164.151,167.647,170.063,173.895,176.145,177.808,180.72,183.136,184.8,188.296,191.176,193.606,197.854,199.93400000000003,202.337,204.753,209.001,212.841,215.206,219.534,223.782,228.11,232.27,233.934,237.51,239.926,241.59,245.838,250.078,252.397,255.973,260.221,264.541,266.911,271.238,272.902,277.15,281.478,285.054" svgx:width="0.56,0.53,0.45,0.29,0.45,0.44,0.3,0.48,0.29,0.21,0.36,0.3,0.21,0.44,0.36,0.55,0.53,0.26,0.55,0.3,0.53,0.48,0.55,0.54,0.53,0.54,0.52,0.21,0.45,0.3,0.21,0.53,0.53,0.55,0.45,0.53,0.54,0.55,0.54,0.21,0.53,0.54,0.45,0.21" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">Characteristics of the population and global</text>
   <text y="295.03" x="56.523,60.771,64.931,67.347,70.843,75.091,81.586,85.323,88.235" svgx:width="0.53,0.52,0.3,0.44,0.53,0.81,0.48,0.36,0.17" style="fill:rgb(19,20,19);font-family:AdvTTb5929f4c;font-size:8.0px;stroke:none;">outcomes.</text>
   <text y="307.162" x="56.523,60.604,64.391,67.744,68.934,71.036,76.72,80.073,83.86,85.316,88.445,92.15499999999999,94.281,96.101,97.557,102.219,105.79,107.61,109.702,112.761,116.114,119.243,121.28,123.8,261.186,264.539,267.899,269.974,271.794,275.147,278.533,282.048,285.401,288.754" svgx:width="0.58,0.54,0.48,0.17,0.55,0.81,0.48,0.54,0.21,0.45,0.53,0.55,0.26,0.21,0.67,0.5,0.26,0.55,0.44,0.48,0.45,0.29,0.36,0.55,0.48,0.48,0.55,0.26,0.48,0.48,0.5,0.48,0.48,0.26" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Age, median (IQR) years 55 (48–60)</text>
   <text y="320.202" x="56.523,61.913,65.042,66.498,69.851,71.041,73.134,76.851,80.568,81.758,261.186,264.539" svgx:width="0.77,0.45,0.21,0.48,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Male, no. 59</text>
   <text y="333.184" x="56.523,60.023,61.479,62.935,66.064,68.178,71.531,73.568,76.697,78.167,80.278,81.734,85.374,89.091,92.871,95.018,97.132,99.169,102.298,106.015,108.563,112.35,113.897,117.026,120.743,122.857,124.047,126.144,129.861,133.578,134.768,261.187,264.54" svgx:width="0.5,0.21,0.21,0.45,0.3,0.48,0.29,0.45,0.21,0.55,0.21,0.52,0.53,0.54,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.21,0.45,0.53,0.3,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Bilateral lung transplant, no. 51</text>
   <text y="346.167" x="56.523,60.898,64.615,66.071,67.527,70.656,72.77,76.123,78.159,81.288,82.758,84.87,88.587,90.407,92.524,93.98,97.62,101.337,105.117,107.264,109.378,111.415,114.544,118.261,120.809,124.596,126.144,129.273,132.99,135.104,136.294,138.39,142.107,145.824,147.014,261.188,264.541" svgx:width="0.63,0.53,0.21,0.21,0.45,0.3,0.48,0.29,0.45,0.21,0.55,0.53,0.26,0.55,0.21,0.52,0.53,0.54,0.55,0.3,0.29,0.45,0.53,0.36,0.54,0.21,0.45,0.53,0.3,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Unilateral of lung transplant, no. 49</text>
   <text y="359.207" x="56.523,60.604,64.104,68.185,72.119,76.494,79.714,81.809,83.265,84.735,86.854,89.402,92.461,96.178,98.215,101.568,102.758,104.883,110.567,113.92,117.707,119.163,122.292,126.002,128.128,129.948,131.404,136.065,139.637,141.457,261.187,264.54,267.90000000000003,269.974,271.794,275.147,278.5,280.537,283.978,287.331" svgx:width="0.58,0.5,0.58,0.56,0.63,0.46,0.55,0.21,0.21,0.55,0.36,0.44,0.53,0.29,0.48,0.17,0.55,0.81,0.48,0.54,0.21,0.45,0.53,0.55,0.26,0.21,0.67,0.5,0.26,0.55,0.48,0.48,0.55,0.26,0.48,0.48,0.29,0.48,0.48,0.26" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">APACHE II score, median (IQR) 19 (16-23)</text>
   <text y="372.189" x="56.523,60.023,63.376,65.924,69.711,71.167,73.204,76.333,78.446,82.163,84.2,87.28,89.406,90.862,94.578,96.398,99.751,102.81,104.996,106.452,110.169,113.886,115.076,117.185,120.902,124.619,125.809,261.186,264.539" svgx:width="0.5,0.48,0.36,0.54,0.21,0.29,0.45,0.3,0.53,0.29,0.44,0.55,0.21,0.53,0.26,0.48,0.44,0.3,0.21,0.53,0.53,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Respiratory infection, no. 39</text>
   <text y="385.172" x="56.523,60.023,63.376,64.832,68.185,71.244,73.358,74.814,78.53,82.247,83.437,85.551,89.268,92.985,94.175,261.186,264.539" svgx:width="0.5,0.48,0.21,0.48,0.44,0.3,0.21,0.53,0.53,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">Rejection, no. 29</text>
   <text y="398.155" x="56.523,59.729,63.089,65.197,69.495,71.532,74.661,78.448,81.80799999999999,83.906,87.266,89.406,92.905,97.203,101.718,102.908,104.996,108.713,112.43,113.62,261.186,264.539" svgx:width="0.46,0.48,0.55,0.61,0.29,0.45,0.54,0.48,0.55,0.48,0.55,0.5,0.61,0.64,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">T0 Grade 3 PGD, no. 50</text>
   <text y="411.194" x="56.523,59.729,63.082,66.44200000000001,68.542,72.84,74.877,78.005,81.792,85.152,87.308,90.668,92.75,96.25,100.548,105.063,106.253,108.341,112.058,115.775,116.965,261.186,264.539" svgx:width="0.46,0.48,0.48,0.55,0.61,0.29,0.45,0.54,0.48,0.55,0.48,0.55,0.5,0.61,0.64,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">T24 Grade 3 PGD, no. 33</text>
   <text y="424.177" x="56.523,59.729,63.082,66.44200000000001,68.542,72.84,74.877,78.005,81.792,85.152,87.308,90.668,92.75,96.25,100.548,105.063,106.253,108.341,112.058,115.775,116.965,261.186,264.539" svgx:width="0.46,0.48,0.48,0.55,0.61,0.29,0.45,0.54,0.48,0.55,0.48,0.55,0.5,0.61,0.64,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">T48 Grade 3 PGD, no. 25</text>
   <text y="437.16" x="56.523,59.729,63.082,66.44200000000001,68.542,72.84,74.877,78.005,81.792,85.152,87.308,90.668,92.75,96.25,100.548,105.063,106.253,108.341,112.058,115.775,116.965,261.186,264.539" svgx:width="0.46,0.48,0.48,0.55,0.61,0.29,0.45,0.54,0.48,0.55,0.48,0.55,0.5,0.61,0.64,0.17,0.55,0.53,0.53,0.17,0.55,0.48,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">T72 Grade 3 PGD, no. 22</text>
   <text y="450.199" x="56.523,57.979,61.913,66.323,68.372,74.055,77.772,79.881,81.995,85.124,86.58,88.036,90.15,93.209,94.399,96.492,100.209,103.926,105.116,261.186" svgx:width="0.21,0.56,0.63,0.55,0.81,0.53,0.29,0.3,0.45,0.21,0.21,0.3,0.44,0.17,0.55,0.53,0.53,0.17,0.55,0.48" style="fill:rgb(0,0,0);font-family:AdvTTb5929f4c;font-size:7.0px;stroke:none;">ICU mortality, no. 9</text>
   <text y="39.005" x="56.523,60.939,63.435,65.179,67.675,69.419,72.747,76.907,78.667,81.014,85.43,89.59,92.086" svgx:width="0.55,0.31,0.22,0.31,0.22,0.42,0.52,0.22,0.55,0.55,0.52,0.31,0.45" style="fill:rgb(19,20,19);font-family:AdvTT7329fd89.I;font-size:8.0px;stroke:none;">Critical Care</text>
   <text y="39.005" x="98.021,102.101,106.181,110.261,114.341,115.94099999999999,118.261,122.677,127.005,128.837,133.165,139.829,143.829,146.154,150.234,154.31400000000002,156.699,160.611,164.939,169.435,173.931,175.77100000000002,178.129,182.209,484.155,488.403,492.235,496.651,500.651,502.977,507.057,511.137,515.217,517.604,521.932,524.2520000000001,526.675,530.755,534.835" svgx:width="0.51,0.51,0.51,0.51,0.2,0.55,0.55,0.54,0.23,0.54,0.83,0.5,0.55,0.51,0.51,0.55,0.49,0.54,0.56,0.56,0.23,0.55,0.51,0.55,0.53,0.48,0.55,0.5,0.55,0.51,0.51,0.51,0.55,0.54,0.29,0.55,0.51,0.51,0.51" style="fill:rgb(19,20,19);font-family:AdvTTe45e47d2;font-size:8.0px;stroke:none;">2016, Volume 20 Suppl 2 Page 110 of 182</text>
  </g>
 </g>
</svg>
